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Reversible S-palmitoylation confers spatiotemporal control of protein function by
modulating protein stability, trafficking and activity as well as protein-protein and
membrane-protein associations. While it is evident that palmitoylation is regulated in
vivo, mechanisms that mediate cellular stimuli-driven changes of the lipid modification
are not understood. Furthermore, the requirement for substrate specificity among the
highly redundant palmitoyl acyltransferases (PATs) remains unresolved.
To study the regulation of PATs and palmitoylomes, I developed bioorthogonal
chemical strategies for improved analysis of dynamic palmitoylation in mammalian cells.
I showed that alkyne-functionalized fatty acids, in conjunction with azido-fluorophores,
provide the most sensitive detection of acylated proteins following CuI-catalyzed azidealkyne cycloaddition. Linkage-specific hydrolysis, mutagenesis and inhibitor studies
reveal that these alkynyl-fatty acids are incorporated into proteins by endogenous fattyacylation machinery via native linkages at specific amino acid residues. In addition,
shorter and longer chain fatty acids label myristoylated and palmitoylated proteins
respectively. Since myristoylation is co-translational and constitutive, I employed both
palmitoylation and myristoylation chemical reporters with orthogonal fluorophores to

simultaneously monitor palmitate and protein turnover. Dual pulse-chase analysis of Lck,
a tyrosine kinase required for T-cell signaling, revealed accelerated palmitate cycling
upon T-cell activation. Pharmacological perturbation of Lck palmitate turnover suggests
yet uncharacterized serine hydrolases contribute to dynamic palmitoylation in cells.
These significant improvements allow rapid and robust biochemical analysis of
palmitoylated proteins without overexpression, facilitating the functional characterization
of cellular factors and drugs that modulate protein palmitoylation.
Taking advantage of the sensitive bioorthogonal detection of protein
palmitoylation and the simple PAT network in the fission yeast Schizosaccharomyces
pombe, I provided evidence for regulation of PATs and palmitoylomes in vivo at
physiological enzyme and substrate concentrations. I showed that the Erf2-Erf4 PAT
modulates sexual differentiation, and that upregulation of its expression is required to
establish the meiotic palmitoylome. Importantly, I demonstrated that changes in Erf2Erf4 levels within the physiological range control PAT specificity and result in the
differential palmitoylation of its substrates in vegetative and meiotic cells. Underscoring
the biological significance of controlling PAT levels, Erf2-Erf4 overproduction in
proliferating cells alters the palmitoylome and the subcellular distribution of Rho3, a
major meiotic target, stimulating sexual differentiation in the absence of normal
physiological cues. From this study, I conclude that PAT substrate specificity depends on
enzyme levels and propose the rheostatic control of PAT activity as a mechanism by
which cells shape stimuli-induced palmitoylomes. Future questions stemming from this
work are also discussed.
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CHAPTER 1
GENERAL INTRODUCTION

Post-translational modifications are important for protein function
Post-translational modifications of proteins (PTMs) are important for building functional
complexity of proteomes in living organisms. To date, more than 200 PTMs involving the
covalent attachment of metabolites and other proteins, both static and dynamic, have been
identified. Together, they increase the diversity of functional groups beyond those in the
side chains of the 20-22 proteinogenic amino acids, enabling new chemistry, new
recognition patterns for binding partners as well as control of enzyme activity, protein
stability and location (Fig. 1.1b). The function and regulation of some of these
modifications such as phosphorylation have been extensively studied and characterized.
In contrast, our understanding of modifications such as S-palmitoylation, the focus of this
thesis, is limited.
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Figure 1.1 | Post-translational modifications (PTMs) are important for protein function. a,
Different covalent modifications of proteins, depicted by red circles, generate proteome
complexity and diversify protein function. b, Examples of PTMs (red) of indicated amino acid
side chains. Major forms of protein lipidation are indicated in box.

Protein S-palmitoylation
Lipid modifications, myristoylation, palmitoylation and prenylation (Fig. 1.1b, box),
increase protein hydrophobicity, primarily functioning as lipid anchors to stabilize
protein-membrane interactions and in some cases directly regulate protein activity as well
as protein-protein interactions. These distinct lipid modifications differ not only in
chemical linkage, chain length and degree of saturation of the lipids, but also in the
associated enzymes, which recognize discrete protein substrates. S-Palmitoylation, also
known as S-acylation, is the only reversible lipid modification - the palmitate turns over
faster than the protein itself1, 2. Palmitoylation takes place on the thiol side chains of
cysteine residues post-translationally via thioester linkages (Fig. 1.2). Although it
typically involves attachment of a saturated 16-carbon palmitate group to proteins,
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incorporation of longer fatty acids with different degrees of unsaturation have been
reported3-5. Some proteins, such as the secreted Sonic hedgehog morphogen6-9, are
irreversibly palmitoylated through the formation of an N-terminal amide bond (Npalmitoylation) but in this thesis, palmitoylation refers to S-palmitoylation. To date, there
is no unique consensus site, making it challenging to accurately predict palmitoylated
proteins and modification sites.

Figure 1.2 | Protein S-palmitoylation is a reversible modification. Palmitate is installed on the
thiol side chain of a cysteine residue through the formation of a thioester linkage (red).
Palmitoylation and depalmitoylation are mediated by a family of palmitoyl acyltransferases
(PATs) and thioesterases, respectively. No reliable consensus palmitoylation sequence has been
identified.

Nonetheless, recent technical advancements enabled comprehensive global
characterization of palmitoyl-proteomes (palmitoylomes) in yeast and mammalian cells,
which reveal that ~1-2% of proteomes are modified10-18. These studies greatly expanded
the known complement of palmitoylated proteins and indicated important roles for this
lipid modification as a major cellular regulator in diverse biological processes such as
cell death and proliferation, immune signaling and neuronal function (Table 1.1). In this
chapter, I will discuss how palmitoylation impacts protein function (Part 1) and how this
modification is regulated in cells (Part 2).
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Table 1.1 | Representative palmitoylated proteins.
Protein family

Substrate

Reference

*HRAS, *NRAS

Hancock et al.20
*Baker et al.131
*Rocks et al.22

*RHOB

Adamson et al.167
*Kang et al.11

*Brain-specific CDC42 isoform 2

*Kang et al. 11

*Gαs, *Gαq, *Gα12

Linder et al.219
Wedegaertner et al.182
*Degtyarev et al.55
*Wedegaertner et al.54

FYN

Koegl et al.110
Shenoy-Scaria.115

*LCK

Koegl et al.110
Shenoy-Scaria.115
*Zhang et al.52

GAP43 (neuromodulin)

Skene et al.183

*eNOS

Liu et al.218
*Ho et al.40

Huntingtin

Yanai et al.50

CaMK1G

Takemoto-Kimura et al.184

GAD65

Christgau et al.

Stathmin 2 (SCG10)

Grenninglog et al.217

Signaling proteins

Small GTPases

G protein α subunits

Non-receptor tyrosine
kinases

Other signaling proteins

Channels, receptors, transporters other transmembrane proteins

G protein-coupled
receptors

Rhodopsin

OʼBrien et al.185

*β2-adrenergic receptor

OʼDowd et al.216
*Mouillac et al.53

GluR1, GluR2

Hayashi et al.215
*Kang et al.11

Large conductance (BK) K+ channel

Tian et al.88

Integrin α6

Yang et al.186

CD9 (tetraspannin 29)

Yang et al.214

FAS

Chakrabandhu et al.187

Ion channels

Cell adhesion molecules

Cell death signaling
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Table 1.1 continued |
Protein family

Substrate

Reference

*PSD95 (Post Synaptiic Density protein 95)

Topinka & Bredt213
*El-Hussini et al.39

GRIP1, GRIP2

DeSouza et al.212

LAT (Linker for Activation of T-cells)

Zhang et al.31

Adaptors and scaffolds

Proteins involved in protein sorting and vesicle trafficking
SNAP25B

Hess et al.211

*Syntaxin1, Syntaxin 6

Martin et al.13
*Kang et al.11

Synaptobrevin 2

Martin et al.13
Kang et al.11

Synaptotagmins

*Synaptotagmin 1

Heindel et al.188
*Kang et al.11

Others

CSP

Chamberlain & Burgiyne189

*CKAP4 (p63)

Schweizer et al.210
*Mundy & Warren56

IFITM3

Yount et al.16

SNAREs

*Changes in palmitoylation states have been associated with different cellular or physiological
states.

Part 1: Palmitoylation-mediated regulation of protein function
Protein targeting and trafficking
Palmitoylation primarily targets proteins to specific membrane compartments in the cell.
The small GTPase Ras, an important molecular switch in diverse signaling networks
governing cell death, proliferation, differentiation that is well-known for its role in cancer
development19, provides an important paradigm for spatial control mediated by this lipid
modification. Nras and Hras are two highly homologous isoforms, differing mainly in
their hypervariable C-terminal regions, where Nras and Hras are both prenylated and
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either mono- or dual- palmitoylated2,

20, 21

(Fig. 1.3a). These isoforms have distinct

cellular distribution with Hras being more enriched at the plasma membrane relative to
the Golgi22 (Fig. 1.3a). This is dependent on their palmitoylation states since localization
of mono-palmitoylated Hras mutants more closely resemble Nras22 (Fig. 1.3b). Notably, a
non-palmitoylated Hras mutant is randomly distributed to all membranes (Fig. 1.3b,
C181, 184S), indicating that prenylation alone is insufficient to target proteins to specific
membranes22. In fact, it is appreciated that other lipid modifications such as
myristoylation and prenylation (Fig. 1.1b) act as weak membrane anchors while
palmitoylation, although not usually the primary membrane association signal, is a strong
membrane anchor that specifies the membrane distribution of a protein23 (Fig. 1.3d, steps
1-3). The reversibility of palmitoylation is also crucial for its function. Microinjection of
a semisynthetic Nras that is irreversibly-linked to palmitate results in non-specific
distribution of the protein (Fig. 1.3c), demonstrating that correct localization of Nras
requires both palmitoylation and depalmitoylation22 (Fig. 1.3d). Cycles of palmitoylation
and depalmitoylation govern protein-membrane associations, allowing key signaling
proteins to shuttle and relocalize between intracellular membrane compartments22, 24, 25.

6

Figure 1.3 | Dynamic palmitoylation regulates localization of Ras isoforms. a, Distinct
cellular distribution of two YFP-tagged Ras isoforms, Nras and Hras, which are mono- and
dually- palmitoylated, respectively. Both isoforms are also prenylated. b, Palmitoylation
determines membrane-specific localization of Hras. Cellular distribution of YFP-tagged Hras
palmitoylation mutants, C184S, C181S or C181, 184S. Box, overexposed area reveals
endoplasmic reticulum (ER) and plasma membrane (PM) localization of the C181S Hras mutant.
c, Cellular distribution of synthetically-derived Cy5-labeled Nras with either native thioesterlinked or a non-cleavable thioether-linked palmitate upon microinjection into cells. a-c, Adapted
from Rocks et al.22. d, Model for how palmitoylation regulates Ras trafficking. Newly
synthesized Ras is prenylated and reversibly binds ER and Golgi membranes and traffic between
them via a soluble cytosolic intermediate (step 1). Palmitoylation by a palmitoyl acyltransferase
(PAT) kinetically traps Ras onto membranes in the early secretory pathway (step 2) and enables
trafficking to the PM (step 3). Palmitate turnover generates a transiently depalmitoylated pool of
protein that is returned to the Golgi and/or ER compartments by non-vesicular transport, where it
again can interact with PATs at the Golgi and/or ER and reenter the secretory pathway (step 4).
Adapted from Goodwin et al.24
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Spatial compartmentalization increases the complexity of signal outputs
By influencing their subcellular distribution, dynamic palmitoylation can have critical
effects on the function and signaling outputs of proteins as epitomized by
compartmentalized Ras signaling. Studies indicate that a Ras protein signals though
distinct downstream effectors and pathways from a variety of membrane compartments22,
26,

addressing the conundrum of how a binary molecular switch like Ras, which cycles

between GTP-bound active and GDP-bound inactive forms, can selectively control
multiple pathways (Fig. 1.4). Unambiguously showed by Onken and colleagues using the
single Ras protein in fission yeast27, 28 (Fig. 1.4b), compartmentalized Ras signaling also
explains how the different Ras isoforms in mammals, though highly homologous and
indistinguishable in most in vitro assays, perform non-overlapping biological functions19.
In addition to maintaining the differential subcellular distribution of Hras and Nras
isoforms, different de/repalmitoylation kinetics account for isoform-specific activation
responses by regulating their partitioning between membrane compartments22, 24. It is
clear that compartmentalized signaling increases the complexity of signaling outputs but
it remains to be determined how palmitoylation, with its potential to impart rapid
spatiotemporal control of protein function, affects distribution of signals across multiple
platforms and influences the selectivity of signal outputs.

8

Figure 1.4 | Palmitoylation-modulated compartmentalized Ras signaling increases the
complexity of signaling outputs in a, Mammals and b, fission yeast. Palmitoylated and nonpalmitoylated Ras proteins localize to different membrane platforms, where they signal through
different effectors and pathways involved in important cellular processes/events as indicated. PM:
plasma membrane.

Membrane microdomains as signaling platforms
Palmitoylation is also important for controlling the lateral segregation of proteins into
membrane microdomains such as lipid rafts, which are ordered assemblies of proteins
and lipids enriched in sterols and sphingolipids29. Several lines of evidence from studies
in immune cell signaling suggest that this lipid modification functions modulates raft
association of proteins. First, palmitoylation of proteins such as non-receptor tyrosine
kinases Lck and Fyn, adaptor LAT, as well as co-receptors CD4 and CD8 are critical for
T-cell signaling. Disruption of palmitoylation results in loss of raft association by these
proteins, which is concomitant with abrogation of T-cell signaling3,

30-35.

Second,

substitution of palmitate on Lck with a more hydrophilic oxygen-substituted palmitate
analog that disrupts lipid packing also reduces raft association and weakens its signaling
activity36. Third, although artificial targeting of chimeric Lck and LAT constructs to the
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plasma membrane without raft association restored their function in T-cell signaling, their
signaling properties are altered37,

38.

Together, these observations strongly indicate

palmitoylation-mediated targeting to membrane microdomains can affect the function and
signaling outputs of proteins.
How does targeting to membrane microdomains affect protein activity? The
concept of compartmentalized signaling described previously can be applied to laterally
divided subdomains within the same membrane compartment. Palmitoylation partitions
proteins to common membrane microdomains or raft environments that are miscible,
facilitating particular protein-protein interactions (Fig. 1.5a). In contrast, interactions
between proteins in two non-miscible environments are less favored (Fig. 1.5b). By
changing the lateral distribution of proteins within the same membrane compartment,
palmitoylation can rapidly and reversibly modulate protein-protein interactions.

Figure 1.5 | Model for regulation of protein-protein interactions by palmitoylation-mediated
microdomain association. a, Palmitoylation targets proteins to common membrane
microdomains or raft environments that are miscible, thereby facilitating dynamic protein-protein
interactions. b, Interactions between proteins in two non-miscible environments are less favored.
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Interestingly, many peripheral and transmembrane proteins required for signaling
at neuronal and immune synapses are palmitoylated31,

39-41,

suggesting a tantalizing

possibility of lipid rafts as signaling platforms where reversible palmitoylation can
rapidly regulate signaling strength by coordinating various lipid-protein and proteinprotein associations42.

Beyond membrane targeting
Besides inter- and intra- membrane targeting, palmitoylation controls protein activity in
diverse ways such as inducing protein conformational changes43, 44, modulating protein
stability45-49 and aggregation50 as well as interacting with a variety of PTMs. Crosstalk
between palmitoylation and other PTMs will be elaborated later in this chapter.
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Part 2: Regulation of protein palmitoylation
As reviewed in Part 1, palmitoylation controls various aspects of protein distribution and
function. Given its versatility and reversibility, palmitoylation is a potential major cellular
regulator akin to phosphorylation. If this were true, one expects palmitoylation to be
actively regulated and that this will have functional consequences on cellular physiology.
This is best exemplified by the neuronal scaffold PSD95. Receptor activity-regulated
palmitate turnover of PSD95 modulates synaptic strength and plasticity in post-synaptic
neurons by mediating receptor clustering39, 51. Importantly, this effect is specific since
palmitoylation of other neuronal proteins, GluR2 and GRIP1, is unaffected under the
same conditions51. Besides neuronal activity, other extracellular signals have been shown
to alter the palmitoylation state or rate of palmitate turnover in different cell types (Table
1.1, *proteins). Accelerated depalmitoylation of G-protein subunits, G-protein coupled
receptors and a non-tyrosine kinase Lck upon receptor stimulation suggest active
regulation of de/re-palmitoylation52-55. Additionally, a broader level of control is
suggested by global changes in palmitoylomes that are associated with specific
physiological states of the cell or organism11,

56.

While it is clear that this lipid

modification is regulated in vivo, the field is in its early days and little is known of how
these changes in palmitoylation states occur and how they affect cellular function.
Similar to how phosphorylation is regulated by protein kinases and phosphatases,
it is conceivable that enzymes catalyzing the palmitoylation and depalmitoylation
reactions are regulated. Here, I review the evidence for regulation of these enzymes and
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the other mechanisms that modulate protein palmitoylation as well as what these mean in
terms of cellular function.

Palmitoyl acyltransferases (PATs)
A family of Asp-His-His-Cys-containing palmitoyl acyltransferases (DHHC-PATs) found
in all eukaryotes examined is responsible for most protein palmitoylation events12.
Discovered in Saccharomyces cerevisiae, AKR157 and ERF2-ERF458 are instrumental
towards understanding the enzymology of protein palmitoylation. ERF2 requires an
additional cofactor ERF4 for catalyzing palmitate transfer to its substrates58, as does its
mammalian DHHC9 homolog59, while AKR1 exhibit sufficient activity by itself like
most other PATs. ERF2 and AKR1 are integral membrane proteins with 4 and 6
transmembrane domains respectively, with the conserved DHHC domain that is required
for catalytic activity facing the cytosol60 (Fig.1.6a). Demonstrated by two groups using
ERF2-ERF4 and mammalian PATs, DHHC2 DHHC3 and DHHC9-GCP16, PATs catalyze
palmitoylation via a two-step ping-pong mechanism first involving autopalmitoylation of
the enzyme followed by palmitoyl transfer to protein substrates61, 62. Although mutation
of the conserved cysteine in the DHHC motif abrogates both autopalmitoylation and
transfer57, 58, 61-63, there still lacks definitive evidence that it is the catalytic cysteine due to
the current inability to isolate and identify the palmitoyl-enzyme intermediate.
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Figure 1.6 | Structure of PATs. a, PATs are integral membrane proteins with typically 4 or 6
predicted transmembrane domains. The conserved DHHC motif required for catalytic activity is
located on the cytoplasmic face. Adapted from Young et al.64 b, Domain structures of
representative human PATs. Besides a DHHC core domain, each DHHC protein has individual
protein–protein-interacting domains such as a PDZ-binding motif, an SH3 domain and ankyrin
repeats. Blue and green backgrounds show the DHHC2/15 and DHHC3/7 subfamilies,
respectively. Adapted from Fukata et al.41
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PAT-substrate specificity
The multiple DHHC-containing PATs in an organism, ranging from a handful in
unicellular fungi to more than twenty in metazoa, raise intriguing questions about
substrate specificity and regulation.
On one hand, most studies support the notion that specific PAT-substrate pairs are
needed for palmitate transfer. A systematic screen of all 23 mammalian PATs by gain- and
loss- of-function studies revealed that only a subset of PATs (DHHC2, 3 and 7)
quantitatively increase palmitoylation of a model substrate PSD9565. Palmitoylome
analysis of various PAT-deficient mutants in budding yeast provided clear evidence for
PAT-substrate specificity with individual PATs showing a preference for substrates with
common features12. For example, ERF2-ERF4 substrates tend to be heterolipidated (e.g.
myristoylated or prenylated), SWF1 substrates tend to be transmembrane proteins and
AKR1 preferentially modifies soluble hydrophilic proteins12. Evidence of specificity
determinants on both substrates66 and enzymes67 further supports substrate specificity
among members of the PAT family. Huang and co-workers demonstrated that transfer of
the HIP14/DHHC17 ankyrin repeat domain to DHHC3 enabled it to modify huntingtin, a
HIP14/DHHC17 substrate67, highlighting the importance and potential of domains
outside the DHHC domain in regulating PAT-substrate specificity and function (Fig.
1.6b).
On the other hand, a recent study examining the kinetics of membrane association
and partitioning of microinjected semisynthetic fluorescent lipopeptides suggested that
protein palmitoylation was neither stereoselective nor sequence-specific and that
substrate specificity was not required for dynamic palmitoylation in cells68. This is
15

supported by Hou and colleagues, who showed strong biochemical and functional overlap
between the different PATs in budding yeast69. A potential concern for these studies is the
use of non-physiological concentrations of substrates and/or enzymes, which may be
accompanied by loss of PAT specificity.
Nonetheless, it is evident and consistent among the different studies that there is
to a certain extent, biochemical and functional overlap between multiple PATs in
organisms12, 65, 68, 69, which makes understanding their roles in regulating global protein
palmitoylation and cellular physiology challenging.

Differential regulation of PATs
Physiological state-dependent changes in the palmitoylation of individual proteins and in
palmitoylomes suggest mechanisms by which PATs “sense” regulatory inputs and
coordinate differential modification of its substrates. To date, there is little evidence for
regulation of PATs and how it impacts protein palmitoylation as well as cellular function.
Specific PATs were found to have different subcellular locations and tissuespecific distribution70, 71, suggesting the possibility that PAT localization and expression
levels may be important for cellular function. As the first documentation of differential
PAT regulation, Noritake and colleagues showed in neurons that activity-sensitive
DHHC2 translocation enhances PSD95 palmitoylation and synaptic receptor clustering51.
Although how PAT localization is determined and altered in response to synaptic activity
is unclear, such stimulus-specific compartmentalization of PAT function may be a general
mechanism to regulate protein palmitoylation. Recent studies by the Chamberlain lab
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identified sorting signals on several PATs that target these enzymes to defined membrane
compartments as well as regulate PAT cycling between compartments72, 73.
PATs may also be regulated by PTMs such as palmitoylation and ubiquitination18,
74, 75.

Interestingly, ubiquitination and subsequent proteasome-mediated degradation of

DHHC5 were observed when cultured neural stem cells were induced to differentiate74.
Nonetheless, it remains to be determined how induced PAT degradation affects substrate
palmitoylation and impacts neuronal differentiation. From a bigger picture, are PATs
modified by other PTMs and how do they regulate PAT function?
Further supporting that PATs have distinct substrates and modulate specific
physiological functions, misregulation and mutation of specific PATs in mammals are
involved in different neurological and developmental defects as well as various cancers
(Table 1.2). Given the importance of PAT-mediated palmitoylation in many biological
systems, it is important to elucidate mechanisms that control PAT activity in
physiologically relevant contexts.

17

Table 1.2 | PATs involved in human diseases
Disease

Model

PAT

Observations

Reference

Neurological diseases

Huntington
disease (HD)

Alzheimerʼs

In vitro

ZDHHC17
/HIP14

Weaker huntingtin (HTT)–HIP14 interaction and
reduced palmitoylation in presence of diseasecausing mutation in HTT.

Mouse

ZDHHC17
/HIP14

Reduced HTT palmitoylation in mouse model of
HD.

Mouse

ZDHHC17
/HIP14

Phenotype in mice lacking HIP14 resembles mouse
model of HD.

Singaraja et al.208

In vitro

ZDHHC13
/HIP14L

Reduced HTT palmitoylation in vitro.

Saleem et al.191

Mouse

HIP14,
HIP14L

HTT modulates HIP14 and HIP14L activity.

Huang et al.75

In vitro

ZDHHC12

DHHC12 is involved in amyloid protein precusor
metabolism (including Aβ production).

Mizumaru et al.192

Human

DHHC8

Associated with patients with schizophrenia.

Liu et al.207

Mouse

ZDHHC8

Pre-pulse inhibition deficit in female knockout mice.

Mukai et al.193

Mouse

ZDHHC8

Defective neuron morphology and reduced dendrite
spine density.
ZDHHC8 palmitoylates PSD95.

Mukai et al.206

Human

DHHC9

Severe nonsyndromic XLMR, epileptic seizures,
dysmorphic facial appearance.

Raymond et al.194

Human

DHHC15

Moderate XLMR in males.
Developmental delay.

Mansouri et al.205

Saleem et al.191

Singaraja et al190
Huang et al.209
Yanai et al.50

Schizophrenia

X-linked mental
retardation
(XMLR)

Non-neurological developmental defects
Multiple defects

Mouse

ZDHHC13
/HIP14L

Knockout mice have shortened life spans, global
amyloidosis, and hair, skin, and bone abnormalities.

Hair and skin
defects

Mouse

ZDHHC21

Loss of ZDHHC21 function results in skin
homeostasis and hair follicle differentiation.

Various cancers
and metastasis

Human

DHHC2

Potential tumor suppressor genes for various
cancers are mapped to chromosomal region 8p22
that contains the DHHC2 gene

Oyama et al.203
Qin et al.196

Bladder cancer

Human

DHHC11

Increased copy number of chromosome region
containing DHHC11 gene in bladder cancers with
high malignant potential.

Yamamoto et al.202

Mayer et al.204
Mill et al.195

Cancers
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Table 1.2 continued |
Disease

Model

Non-small lung
cancer

Human

DHHC11

Increased copy number of chromosome region
containing DHHC11 gene in non-small cell lung
cancers.

Kang et al.198

Colorectal
cancer

Human

DHHC9

DHHC9 transcript is upregulated in the majority of
microsatellite stable colorectal tumors but not in
other common cancers.

Mansilla et al.201

Cellular
transformation

Murine
cell line

PAT

Murine
cell line

Reference

DHHC20 overexpression induces cellular
transformation.
Draper et al.199

DHHC20
Overexpressed in several human tumors (ovarian,
breast and prostate)

Human
Cellular
transformation

Observations

ZDHHC17
/HIP14

HIP14 overexpression induces cellular
transformation.

Ducker et al.200

Depalmitoylating enzymes/ protein thioesterases
In contrast to the large PAT family, few protein thioesterases with depalmitoylating
activity have been identified and they are relatively uncharacterized. Biochemical efforts
to purify depalmitoylating enzymes have yielded lysosomal palmitoyl protein
thioesterase 1 (PPT1) and cytosolic acyl protein thioesterase 1 (APT1), both of which can
depalmitoylated proteins in vitro76-78.
PPT1, a lysosomal protein is responsible for degrading palmitoylated proteins, is
thought to be topologically incompatible with depalmitoylating cytoplasmic proteins79.
Nonetheless, recent studies show that PPT1 is also found in presynaptic compartments in
neurons and that it may play a role in synaptic vesicle cycling80, 81.
Consistent with its ability to depalmitoylate Hras and Gαi in vitro77, APT1
overexpression promoted depalmitoylation of Gαs and eNOS in mammalian cultured
cells82 and disruption of APT1 function in budding yeast resulted in decreased palmitate
turnover on GPA1, the yeast Gα homolog78. Treatment of cells with an inhibitor
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(Palmostatin B) designed to target APT1, an α/β serine hydrolase with a canonical serine/
histidine/aspartate catalytic triad83,

84,

increased steady state Ras palmitoylation and

cellular redistribution of Ras proteins84. While this study provides the first evidence that
Ras is a substrate of APT1 in cells, it is possible that this is due to off-target effects of
Palmostatin B on other similar serine hydolases and protein thioesterases including PPT1
and APT283, which has been shown to deacylate GAP43 in cells85. Recently, APT1 was
implicated in neuronal morphogenesis when it was found to be a target of a neuronal
enriched microRNA, miR13886. Down-regulation of APT1 function was associated with
increased association of Gα13 with the membrane and higher dendritic spine volume86. It
would be interesting to see if other palmitoylated proteins in neurons41 are actually APT1
substrates and if they contribute to neuron morphogenesis and activity.
Given the limited number of APT1 substrates that are validated in vivo compared
to diverse proteins that undergo regulated palmitate turnover14, it remains to be
determined if PPT1, APT1 and their related isoforms are the main deacylating enzymes
or if there are potentially more enzymes to be uncovered. As with discovery of the PATs,
identification of the thioesterases would allow perturbation of the palmitoylation/
depalmitoylation cycle and yield insights into the regulation and physiological function
of dynamic palmitoylation.
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Accessibility of modification sites
Protein palmitoylation can be modulated by mechanisms that influence the accessibility
of substrates or modification sites to the palmitoylation or depalmitoylation enzymatic
machinery. An example is the promotion of Ras depalmitoylation by prolyl isomerase
FKBP1287 (Fig. 1.7). Ahearn and co-workers showed that FKBP12 binds to Hras in a
palmitoylation-dependent manner and regulates its trafficking by promoting
depalmitoylation through cis-trans isomerization of a peptidyl-prolyl bond close to
palmitoylated cysteines. Inhibition of FKBP12 prolyl isomerase activity by a variety of
chemical inhibitors such as FK506, rapamycin and cycloheximide increases Hras steady
state palmitoylation87. While only proteins with proline residues close to palmitoylation
sites can potentially be regulated by this mechanism, it is conceivable that any changes in
protein conformation that influence the accessibility of the modification sites, can affect
the palmitoylation/depalmitoylation cycle.

Figure 1.7 | Controlling depalmitoylation by altering the
accessibility of modification sites. FKBP12 binds Hras and
promotes its depalmitoylation by cis-trans isomerization of a
peptidyl-prolyl bond in proximity to the palmitoylated
cysteines.
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Substrate accessibility can also be modulated by crosstalk between different PTMs.
Negatively-charged phosphate groups may prevent palmitoylation of an adjacent cysteine
by preventing association with membranes, where PATs are localized (Fig 1.8a, 1). In a
reciprocal manner, one would also expect palmitoylation to prevent phosphorylation by
blocking access of kinases to nearby serine, threonine or tyrosine residues88-91 (Fig. 1.8a,
2). Nitrosylation competes with the PATs for modification sites (Fig. 1.8b). PSD95 is
physiologically nitrosylated at the same cysteines that are palmitoylated and
physiologically produced nitric oxide (NO) inhibits PSD95 palmitoylation and synaptic
clustering in vivo, demonstrating direct competition between these cysteine
modifications40. Since NO is an established modulator of many biological processes
including synaptic transmission92, dynamic reciprocity between nitrosylation and
palmitoylation may explain how synaptic activity regulates PSD95 palmitoylation as well
as synaptic clustering and activity. Further examination of palmitoylated substrates for
competing cysteine modifications (e.g. nitrosylation and sulfhydration) would help
determine if this is a general mechanism for regulating protein palmitoylation.
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Figure 1.8 | Interplay between palmitoylation and other PTMs. a, Proximity-dependent
reciprocal regulation between phosphorylation and palmitoylation. (1) Negatively-charged
phosphate group (P, yellow circle) prevents palmitoylation of an adjacent cysteine (Cys, red) by
blocking membrane interaction. (2) Palmitoylation-mediated membrane association prevents
access of protein kinases to an adjacent phosphorylation site. b, Direct competition for
modification sites. (1) Nitrosylation (NO (nitric oxide, orange circle) may prevent palmitoylation
by direct competition for cysteine residues (Cys, red) and vice versa. Nitrosylation may deplete
the pool of depalmitoylated substrates available for repalmitoylation. Other cysteine
modifications may have similar regulatory effects. Note that these examples are not mutually
exclusive, nor do they illustrate the full range of effects that these PTMs have on each other.

While it is clear that protein palmitoylation is important for protein function and
is regulated in vivo, the identity and physiological roles of mechanisms that regulate
palmitoylation is limited. In this thesis, I describe the development of chemical tools that
improves the detection and identification of dynamically palmitoylated proteins, present
the fission yeast Schizosaccharomyces pombe as a new model organism useful for PAT
studies and demonstrate a physiologically important mechanism for regulating protein
palmitoylation.
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CHAPTER 2
BIOORTHOGONAL DETECTION OF PROTEIN FATTY-ACYLATION
IN MAMMALIAN CELLS

Introduction
Many cellular proteins are covalently modified by lipids, the addition and removal of
which regulates diverse biological processes ranging from cellular growth and
differentiation to lymphocyte activation and synaptic transmission. In eukaryotes, fatty
acids, isoprenoids and glycosylphosphatidylinositols constitute the three prevalent forms
of lipid modifications. In this chapter, I will be focusing on the two major forms of
protein fatty-acylation, S-palmitoylation and N-myristoylation, which are characterized
by the chain length of the acyl group attached to proteins (Table 2.1).
S-Palmitoylation, also known as S-acylation, is the only characterized reversible
lipid modification that takes place on the thiol side chains of cysteine residues posttranslationally via a thioester linkage1. Although it typically involves attachment of a
saturated 16-carbon palmitate to proteins, incorporation of longer fatty acids with
different degrees of unsaturation have been reported3-5. Unlike N-myristoylation, there is
no unique consensus palmitoylation motif, making it difficult to accurately predict
palmitoylated proteins and modification sites. The functional role of palmitoylation in
physiology and disease is covered in Chapter 1.
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Table 2.1 | N-Myristyolation and S-palmitoylation are two major forms of protein fattyacylation in eukaryotes.
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Myristoylation is the irreversible attachment of a saturated 14-carbon myristate to Nterminal glycine resides of proteins that is mediated by N-myristoyltransferases
(NMTs)93. Although myristoylation predominantly occurs during protein translation, it
can occur post-translationally on N-terminal glycine residues revealed by proteolytic
cleavage of protein substrates94. Studies indicate that myristoylation promotes weak
transient protein-membrane associations that would be further stabilized by a second
signal such as palmitoylation23. In addition to being an essential modification95, 96, protein
myristoylation has been implicated in infectious and neurological diseases as well as
various cancers97. This is exemplified by different classes of myristoyl switch proteins, of
which conformation changes modulates accessibility of the myristate group and thus their
interactions with the membranes and other proteins98-102.
Given the critical role of fatty-acylation in modulating protein behavior, the
ability to detect, characterize and probe their involvement in cellular function is
important. Traditional autoradiographic detection of radioactive (3H or

14C)

fatty acids

that are metabolically incorporated into proteins, while effective, requires exposure times
spanning days or weeks. Radioactive iodinated (I125)-fatty acids improves detection time
but are hazardous and not readily available103. These limitations are circumvented by two
different approaches of visualizing fatty-acylated proteins using streptavidin
immunoblotting (Fig. 2.1). First, the acyl-biotin exchange protocol (ABE) involves the
covalent attachment of biotin-HPDP ( N-[6-(biotinamido)hexyl]-3′-(2′pyridyldithio)propionamide) to free thiols on proteins that are liberated by hydroxylamine
cleavage of thioester-linked palmitate groups104 (Fig. 2.1a). The combination of ABE
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with mass spectrometry-based proteomics using multidimensional protein identification
technology to yeast and neurons has revealed many new S-palmitoylated proteins in
eukaryotes11, 12. However, this approach is limited to S-acylated proteins since the amide
linkages of myristoylated proteins are resistant to hydroxylamine1. Furthermore, it is
limited to the analysis of steady state palmitoylation. Developed by my research advisor,
Dr. Howard Hang, the second approach allows visualization of both myristoylated and
palmitoylated proteins. This bipartite labeling approach involving metabolic
incorporation of azide-functionalized fatty acids followed by selective addition of
phosphine-biotin probes via Staudinger ligation 105 (Fig. 2.1b). While these
complementary approaches offer rapid and convenient detection of fatty-acylation,
immunoblotting methods are not ideal for analyzing quantitative changes in protein fattyacylation necessary for investigating dynamics or regulatory mechanisms.

Figure 2.1 | Non-radioactive immunoblot detection of fatty-acylated proteins in eukaryotes.
a, Acyl-biotin exchange. b, Metabolic labeling and Staudinger ligation.
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I initiated this thesis by developing bioorthogonal methods for improved
fluorescent detection of endogenously expressed fatty-acylated proteins in mammalian
cells. Through comparative analysis of substrates representing different classes of fattyacylated proteins, I demonstrated the fatty acid chemical reporters are indeed taken up by
cells and specifically incorporated into proteins at canonical modification sites via native
linkages. Furthermore, I showed that alkynyl-fatty acid chemical reporters, in
combination with in-gel fluorescence scanning, provide superior and quantitative
detection of fatty-acylated proteins. Finally, Dr. Lun Tsou and I developed a tandem
labeling and detection method to simultaneously monitor dynamic palmitoylation and
protein turnover. The sensitivity and efficiency of this approach should facilitate the
functional characterization of cellular factors and drugs that modulate palmitoylation
dynamics.
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Results
Bioorthogonal detection of protein fatty-acylation in mammalian cells
Advances in bioorthogonal labeling methods employing copper(I)-catalyzed Huisgen [3
+ 2] cycloaddition (CuAAC) or “click chemistry” reaction between alkyl azides and
alkynes (Fig. 2.2b) offered an opportunity to improve the analysis of fatty-acylated
proteins using chemical reporters. To that end, a fellow graduate student in the lab,
Guillaume Charron, synthesized a series of azido- and alkynyl-fatty acids of different
lengths (Fig. 2.2c) as potential chemical reporters as well as a panel of biotinylated (alkbiotin, az-biotin) and fluorescent (alk-rho, az-rho) detection tags (Fig. 2.2d). Together
with another graduate student in the lab, John Wilson, we optimized bioorthogonal
reaction conditions and showed that fluorescence detection of fatty-acylated proteins in
whole cell lysates using alkynyl chemical reporters is more sensitive compared to
radioactive and immunoblot detection methods described previously.
Analysis of protein fatty-acylation at the proteome level, while important, is
biased towards highly abundant proteins in cells where the dynamic range of protein
concentrations can span more than seven orders of magnitude106-108. By immunopurifying
proteins of interest prior to CuAAC (Fig. 2.2a), I was able to detect chemical reporter
incorporation into substrates representing different classes of fatty-acylated proteins: Spalmitoylated Linker for Activation of T-cells (LAT)31, N-myristoylated and Spalmitoylated Lck109, 110, as well as S-palmitoylated and S-prenylated Ras2, 20, 21 (Fig. 2.3).
Fluorescence at the expected molecular weight of each substrate was only observed in
samples that were metabolically labeled with the fatty acid chemical reporters (Fig 2.3b).
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Figure 2.2 | Analysis of protein fatty-acylation with chemical reporters. a, Metabolic labeling
of mammalian cells with chemical reporters and bioorthogonal labeling of proteins. b, Copper(I)catalyzed Huisgen [3 + 2] cycloaddition or “click chemistry” enables selective covalent
attachment of detection tags to azido or alkynyl substrates. c, Fatty acid chemical reporters. d,
Clickable detection tags.

As a first indication of the specificity of these fatty-acylation chemical reporters,
no fluorescent signal was observed for p53, a non-acylated protein (Fig. 2.3b). This
approach allows analysis of less abundant proteins and focused studies of individual
proteins of interest, detection of which may not be readily apparent at the lysate level.
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Figure 2.3 | Robust fluorescent detection of fatty-acylated proteins. a, Schematic
representation of lipidation sites for LAT (S-palmitoyl-Cys26, S-palmitoyl-Cys29), Lck (Nmyristoyl-Gly2, S-palmitoyl-Cys3, S-palmitoyl-Cys5) and H-Ras (S-palmitoyl-Cys181, Spalmitoyl-Cys184, S-prenyl-Cys186), which represent different classes of fatty-acylated proteins.
b, In-gel fluorescent detection of fatty-acylated proteins in lysates and of immunopurified
proteins. p53, non-fatty-acylated protein.

Fatty acid chemical reporters exhibit chain-length dependent labeling of Nmyristoylated and S-palmitoylated proteins
The ability to assess chemical reporter incorporation into individual proteins allows
evaluation of different detection methods and specificity of the chemical reporters. For
these studies, Jurkat cells were metabolically labeled with azido- or alkynyl- fatty acids
and their incorporation into LAT, Lck and Ras was detected using biotinylated or
fluorescent detection tags. Fluorescent detection of immunopurified fatty-acylated
proteins was markedly improved compared to detection by streptavidin blotting (Fig.
2.4). Longer palmititc acid analogues (az-15, alk-16), which should be incorporated into
all three S-acylated proteins, was nearly undetectable by streptavidin blotting (Fig. 2.4a)
but robustly visualized by in gel fluorescence scanning (Fig. 2.4b). Shorter myristic acid
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analogues (az-12, alk-12), which should label N-myristoylated proteins, are preferentially
incorporated into Lck and to a lesser extent into LAT and Ras by fluorescence (Fig. 2.4b).
This is not unexpected since S-acylation involves a heterogenous composition of fatty
acids3-5.
It is unclear why detection of S-acylated proteins is more efficient with myristic
acid compared to palmitic acid analogues by streptavidin blotting. It is possible that az-12
or alk-12 labeled proteins transfer more efficiently from the gel to the membrane and are
thus better detected by streptavidin blot than the more hydrophobic az-15 or alk-16
proteins. Variability in protein transfer efficiency would be circumvented by direct in-gel
fluorescent detection, which is the more consistent and reproducible detection method
over the multiple repeats of this experiment (data not shown). Notably, the orientation of
alkyne and azide functional groups also influence overall detection sensitivity, with the
alkynyl-chemical probes giving higher signal-to-noise compared to their azide
counterparts (Fig. 2.4b). This is consistent with studies using alkyne- or azidefunctionalized chemical probes111,

112.

Overall, these experiments demonstrate that

alkynyl-fatty acid chemical reporters, in combination with in-gel fluorescence detection,
afford optimal detection of fatty-acylated proteins.
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Figure 2.4 | Alkynyl chemical reporters, in conjunction with in-gel fluorescence scanning,
affords optimal detection of fatty-acylated proteins. a, Comparative analysis of click
chemistry orientation with LAT, Lck and Ras by streptavidin blotting and b, in gel-fluorescence
scanning. *non-specific bands.

Fatty acid chemical reporters are incorporated into proteins at canonical modification
sites via native linkages
In-gel hydroxylamine treatment of alkynyl-fatty acid-labeled Lck and LAT reduced the
fluorescent signal derived from alk-16 on both proteins, but did not alter the alk-12
labeling of Lck (Fig. 2.5a). We also analyzed the specificity of our fatty acid chemical
reporters with wild-type and mutant constructs of p59 Fyn113, a well-characterized Nmyristoylated and S-palmitoylated Src-family kinase, by overexpression in HeLa cells,
metabolic labeling and immunoprecipitation (Fig. 2.5b, c). Fatty-acylation of wild-type
Fyn is readily detected with alk-12 and alk-16 labeling, whereas the N-myristoylation
G2A mutant exhibited significantly reduced alk-12 labeling and was undetectable with
alk-16. The dual S-palmitoylation-deficient C3,6S mutant was efficiently labeled with
alk-12 and not with alk-16. These results are quantitatively identical to previously
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described experiments using radiolabeled fatty acids, which also demonstrated residual
labeling of G2A mutant Fyn with a 125I-myristic acid analogue and no labeling with 125Ipalmitic acid analogue3,

113.

These experiments also support the model that N-

myristoylation precedes S-palmitoylation and highlight the possibility of fatty-acylation
at N-terminal alanine residues. Collectively, our experiments with cell lysates and
specific proteins demonstrate that alk-12 labels N-myristoylated and S-acylated proteins,
whereas longer-chain fatty acid chemical reporters such as alk-16 preferentially target Sacylated proteins.

Figure 2.5 | Fatty acid chemical reporters exhibit linkage and residue specific labeling of
proteins. a, Hydroxylamine sensitivity of alkynyl-fatty acid Lck and LAT labeling in Jurkat cells.
Shown are fluorescence scans of the same gel before and after hydroxylamine treatment. b,
Schematic representation of lipidation sites of Fyn (N-myristoyl-Gly2, S-palmitoyl-Cys3, Spalmitoyl-Cys6). c, Comparative analysis of the acylation states of wild type (WT), G2A mutant
and C3,6S mutant Fyn in HeLa cells.
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Tandem fluorescence imaging of two different protein modifications
An opportunity to visualize two distinct chemical reporters in the same sample arose
when Dr. Tsou developed a set of clickable fluorescent detection tags (az/alk-Cyfur) with
near-IR photophysical properties that are orthogonal to the rhodamine detection tags114.
The following studies were done in close collaboration with Dr. Tsou.

Figure 2.6 | Tandem orthogonal imaging of two different protein modifications. a, Following
metabolic labeling with two chemical reporters, immunopurification and sequential click
chemistry reactions with orthogonal detection tags allow simultaneous visualization of two
protein modifications. b, Fatty acid chemical reporters and clickable fluorescent detection tags. c,
Tandem detection of az-12 and alk-16 on Lck using alk-Cyfur and az-rho respectively. Western
blot is probed for Lck. Lower panels are fluorescence scans of the same gel after hydroxylamine
treatment. *, non-specific bands.
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To explore the simultaneous metabolic labeling and detection of two distinct chemical
reporters, we focused on Lck, an N-myristoylated and S-palmitoylated non-receptor
tyrosine kinase required for T-cell activation110,

115, 116

and exploited the chain-length

specificity between different fatty acid chemical reporters (Fig. 2.5a). Lck was
immunopurified from Jurkat T-cells that were metabolically labeled with either one or
both of the myristate (az-12/alk-12) and palmitate (az-15/alk-16) analogs and subjected to
sequential on-bead CuAAC reactions with az-rho and alk-Cyfur (Fig. 2.6a, b). Washes
after the first reaction removes excess reagents that could quench the second CuAAC
reaction. Orthogonal visualization of the two chemical reporters was achieved with in-gel
fluorescence scanning. At 532 nm excitation/580 nm emission, az-rho signal was
observed for samples labeled with alkynyl-fatty acid reporters (alk-12 and alk-16), while
alk-Cyfur fluorescence at 633 nm excitation/670 nm emission was only detected in with
samples exposed to azido-fatty acid reporters (az-12 and az-15) (Fig. 2.6c, upper panel).
Consistent with the differential biochemical reactivity of thioester and amide linkages1,
in-gel hydroxylamine treatment selectively diminished fluorescence associated with
thioester-linked palmitate analogs (az-15/alk-16) compared to amide-linked myristate
analogs (az-12/alk-12) (Fig. 2.6c, lower panel). These results demonstrate that both sets
of fatty acid chemical reporters are specifically incorporated by N-myristoylation and Spalmitoylation cellular machinery through native chemical linkages. For the first time, we
show sensitive fluorescent detection of dually-modified proteins using two distinct
chemical reporters in parallel. Our tandem imaging method is complementary to copper-
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mediated and copper-free click chemistry strategies that have been used for time-resolved
imaging of single biosynthetic pathways117-120.

Measuring palmitate turnover on proteins using tandem fluorescence imaging
Next, we determined if we can measure palmitate cycling on proteins by using the
tandem imaging method to orthogonally monitor palmitoylation and protein synthesis52.
Traditionally, palmitoylation turnover rates are obtained from pulse chase studies using
3H-palmitate

and

35S-methionine,

with limitations associated with autoradiographic

detection. To monitor palmitate cycling with fluorescence, we envisioned a pulse-chase
experiment employing distinct chemical reporters with orthogonal readouts (Fig. 2.7a) –
one to monitor dynamic palmitoylation and the other to function as an internal control for
protein turnover. Since myristoylation is primarily a co-translational and constitutive
modification1, a myristate analog should function as an efficient chemical reporter for the
amount and loading of myristoylated proteins.
We first evaluated whether incorporation of alk-16 into S-acylated proteins is
reversible in cells. Lck was immunopurified from Jurkat cells that were pulse-labeled
with az-12 and alk-16 followed by a 10-fold excess palmitate chase for different lengths
of time (Fig. 2.7a). Compared to the relatively constant signal of az-12 labeling of Lck,
the fluorescent signal from alk-16 labeling decayed over time (Fig. 2.7b-d). No decrease
of az-12 signal was observed with excess myristate as the chase additive over 6 hours
(Fig. 2.8a), demonstrating that az-12 is an effective chemical reporter of constitutive Nmyristoylation and protein loading. If alk-16 is efficiently recognized by cellular
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thioesterases, we expect the calculated palmitate half-life on Lck using our method to
agree with that of a previously reported pulse-chase study using 3H-palmitate and

35S-

methionine109.

Figure 2.7 | Measuring palmitate turnover on Lck using the tandem imaging method. a,
Scheme of pulse-chase experiment. b, Pulse-Chase analysis of Lck. c, Data from multiple chase
experiments (n=10). Data points from the same chase times, after normalizing alk-16/az-12
signals, were compiled and displayed as average values ± s.e.m. d, Plots of relative signals for
alk-16, az-12 fluorescence and anti-Lck blot intensities in the pulse-chase experiments.
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Figure 2.8 | Pulse-Chase controls. a, In-gel fluorescence scanning in the alk-Cyfur channel
shows no significant turnover of az-12 on Lck upon chasing in the presence of excess myristate.
b, The range of in-gel fluorescence intensities is linear compared to the amount of labeled
substrate.

After confirming our fluorescence measurements are in the linear range (Fig.
2.8b) and normalizing alk-16 to az-12 fluorescent signals, our calculated palmitate halflife on Lck is ~50 minutes (Fig. 2.7c), which is comparable to that reported by Paige et.
al. under similar experimental conditions109. Parallel analysis of another fatty-acylated
kinase, Fyn110, 113, from the same lysates confirmed dual and specific labeling with the
fatty acid reporters. The calculated palmitate turnover rate of Fyn is longer than Lck (Fig.
2.9) and is consistent with the reported estimate of 1.5-2 hours121. These results
demonstrate that the fatty acid reporters and our tandem imaging method can be used to
efficiently and accurately evaluate S-palmitoylation turnover on endogenously expressed
proteins.
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Figure 2.9 | Pulse-Chase analysis of Fyn. Data
from a single pulse-chase experiment after
normalizing alk-16/az-12 signals relative to that of
Lck.

Pevandate stimulation accelerates palmitate
cycling on Lck
Since receptor stimulation has been shown to
increase palmitate turnover on various proteins including G-protein subunits and Gprotein coupled receptors53-55 and palmitoylation of Lck is crucial for T-cell activation38,
122, 123,

we asked whether T-cell activation affects palmitate cycling on Lck. We utilized

pervandate (PV), a phosphatase inhibitor, since it has been shown to trigger an activation
response similar to that of TCR cross-linking124. Anti-phosphotyrosine immunoblots
revealed substantial increase in protein phosphorylation upon PV-treatment (Fig. 2.10)
and mobility shift of Lck due to phosphorylation was also evident from anti-Lck blots
and in-gel fluorescence scans (Fig. 2.10).

Figure 2.10 | Pervanadate stimulation of Jurkat T-cells increases protein phosphorylation
and alters Lck electrophoretic mobility. Analysis of phosphoproteins and Lck electrophoretic
mobility in cells with or without pervanadate (PV) treatment. IPCC, immunoprecipitation-click
chemistry.
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PV treatment resulted in 2-3 fold increase in palmitate cycling on Lck (t1/2 ~15
min) that was reproduced over several experiments (n = 7) (Fig. 2.11a), suggesting T-cell
activation increases dynamic palmitoylation of Lck. The increase in alk-16 signal at later
time points suggest recycling of alk-16 from cellular palmitoyl-CoA pools, which has
been attributed to the discrepancy of palmitate half-life measurements obtained in pulse
chase experiments and imaging studies. Palmitate half-life measurements based on pulsechase experiments are in the order of minutes or hours and are often inconsistent with
rapid physiological responses that can occur on the seconds time scale. Photo-activation/
bleaching of palmitoylated proteins fused to fluorescent proteins estimate protein-bound
palmitate to turnover in milliseconds or seconds22, 24, but these experiments only measure
the protein trafficking and do not the directly evaluate the lipidation state of the protein.
We initially performed 2 hr pulses of the az-12 and alk-16 chemical reporters to
compare our results with reported 3H-palmitate pulse-chase studies109. To address the
effects presented by recycling analog pools, we repeated the experiments with a shorter
pulse time (30 min) prior to chasing with excess palmitate, which has been demonstrated
to minimize recycling of substrates in pulse-chase studies125. The absolute fluorescence
intensities observed for both az-12 and alk-16 were lower overall but they remained in
the linear range. Consistent with less recycling of alk-16, shorter pulses yielded a faster
palmitate half-life of ~30 min on Lck compared to the ~50 min obtained with longer 2 hr
pulses and the normalized alk-16 signal plateaus at a lower level with shorter pulses (Fig.
2.11b). The increase in palmitate turnover on Lck upon PV stimulation, however, persists
with shorter pulse times with an estimated half-life of <5 min (Fig. 2.11c). Notably for
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PV-treated cells, recovery of alk-16 signal was observed even with a shorter pulse time,
which can be attributed to the rapid recycling of alk-16. These results demonstrate our
tandem imaging method can reveal rapid rates of palmitate cycling on proteins that are
closer to values obtained using fluorescence microscopy and that T-cell stimulation with
PV accelerates palmitate cycling on Lck.

Figure 2.11 | Pervanadate stimulation of Jurkat cells accelerates palmitate cycling on Lck. a,
Pulse-chase analysis of Lck in the presence of 0.1 mM pervanadate (PV). PV activation data from
multiple pulse-chase experiments (n = 7). Data points from the same chase times, after
normalizing alk-16/az-12 signals, were compiled and displayed as average values ± s.e.m. (Inset).
b, Pulse-chase analysis of Lck upon PV treatment with a shorter pulse time. c, PV activation data
averaged from two pulse-chase experiments with a shorter pulse time.
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Pharmacological perturbation of Lck palmitate cycling
Efforts to identify enzymes that can depalmitoylate proteins have revealed APT1 and
PPT1 as candidates76-78. Since both enzymes are predicted to be serine hydrolases based
on sequence homology and structure studies, we investigated the effect of a broadspectrum serine hydrolase inhibitor on Lck depalmitoylation. Addition of methyl
arachidonyl fluorophosphonate (MAFP) during the chase significantly retarded palmitate
turnover on Lck (Fig. 2.12a), suggesting that serine hydrolases that are sensitive towards
the reactive fluorophosphonate group of MAFP may contribute to Lck depalmitoylation
in T-cells. In contrast, incubation with another broad-spectrum serine hydrolase inhibitor,
phenylmethylsulfonyl fluoride (PMSF) had no apparent effect on the initial rate of
palmitate removal (Fig. 2.12b). Structural studies suggest that the bulky aromatic group
of PMSF sterically hinders its binding to the active site of lipid serine hydrolases such as
PPT1126. Since PPT1 resides in lysosomal compartments that are not topologically
compatible with cytosolic depalmitoylation reactions79, and APT1 depalmitoylation
activity has only been demonstrated for limited substrates, enzyme(s) that deacylate Lck
in cells remain unclear. Nonetheless, our results with mechanism-based inhibitors suggest
that serine hydrolases with active sites similar to that of PPT1 may contribute to the
observed thioesterase activity on Lck.
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Figure 2.12 | Pharmacological perturbation of palmitate turnover on Lck. a, Pulse-chase
analysis of Lck in the presence of chemical inhibitors. Data from multiple pulse-chase
experiments (n = 2). Data points from the same chase times, after normalizing alk-16/az-12
signals, were compiled and displayed as average values ± s.e.m. b, Pulse-chase analysis of Lck in
the presence of PMSF. Data from pulse-chase experiment after normalizing alk-16/az-12 signals
compared to chase conditions without chemical inhibitors.

We also assessed the effect of 2-bromopalmitate (2BP), a PAT inhibitor commonly
used to block protein palmitoylation30,

127.

Interestingly, 2BP also decreased Lck

depalmitoylation rate (Fig. 2.12a). The actual targets of 2BP in cells are unknown and
several enzymes have been suggested to interact with 2BP128. It is possible that 2BP,
which harbors a reactive α -bromo-carboxyl functional group poised for nucleophilic
attack, might also inhibit putative thioesterases. This raises concerns over the use of 2BP
as a specific PAT inhibitor in cells and subsequent interpretation of the data. Collectively,
these experiments demonstrate that such a dual detection method can be used to evaluate
effects of chemical inhibitors on palmitate turnover. Development of more specific
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inhibitors using this assay should facilitate discovery and characterization of cellular
factors that perturb palmitate turnover in cells.

Tandem imaging method can be generalized to include alternative chemical reporters
To evaluate the utility of our tandem imaging method beyond N-myristoylated proteins,
we employed a general chemical reporter of protein synthesis. Azidohomoalanine (AHA,
Fig. 2.13a), a well-described azide-bearing methionine surrogate shown to label newly
synthesized proteins with no observed toxicity, is an attractive alternative129, 130. We used
an HA-tagged H-RasG12V construct to analyze another class of S-palmitoylated proteins.
In-gel fluorescence analysis of purified HA-tagged H-RasG12V expressed in HeLa cells
that were metabolically labeled with alk-16 and AHA showed incorporation and
orthogonal detection of both chemical reporters (Fig. 2.13b).
We then compared our tandem imaging pulse-chase data with reported radioactive
studies of H-Ras variants131. Palmitate removal rates on oncogenic H-Ras isoforms have
been experimentally shown to be ~1 hr131. Pulse-chase analysis revealed significantly
faster chase kinetics for alk-16 than AHA, demonstrating dynamic S-palmitoylation and
minimal turnover of H-RasG12V in the time points analyzed (Fig. 13b, c). The HA-tagged
H-RasG12V construct appeared as doublets by Cyfur fluorescence and anti-HA western
blot, but only the upper band is modified by alk-16 as observed with az-rho fluorescence,
suggesting the slower migrating polypeptide is the lipid-modified isoform of H-RasG12V
under these conditions. Average Cyfur fluorescence across both H-RasG12V isoforms was
used for data normalization since both exhibited similar turnover rates. The palmitate
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half-life on H-RasG12V was calculated to be ~50 min using our tandem imaging method
over several experiments (n = 5) (Fig. 2.13b). This is consistent with the reported
experimental palmitate turnover rates of other oncogenic H-Ras variants131. Based upon
these experimental rates of palmitate cycling and GTP-binding measurements, the
calculated palmitate half-life of fully GTP-bound H-Ras is less than 10 min. The
combined use of alk-16 with AHA should enable tandem fluorescence imaging of
palmitate turnover on any S-acylated protein. Given its modularity and the wide spectrum
of chemical reporters currently available132, this tandem imaging approach can be readily
adapted to study other dynamic protein modifications.
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Figure 2.13 | Use of a general protein synthesis chemical reporter extends the tandem
imaging method beyond N-myristoylated proteins. a, Amino acid chemical reporter for protein
synthesis. b, Tandem detection of AHA and alk-16 on H-RasG12V in transfected HeLa cells.
Western blot is probed for the N-terminal HA epitope on H-RasG12V. c, Pulse-Chase analysis of
H-RasG12V with AHA and alk-16. Data from multiple pulse-chase experiments (n = 5). Data
points from the same chase times, after normalizing alk-16/AHA signals, were compiled and
displayed as average values ± s.e.m. d, Plots of relative signals for alk-16, AHA fluorescence and
anti-HA blot intensities in the pulse-pulse-chase experiments.
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Summary and Discussion
In this chapter, we have expanded the chemical toolbox for monitoring two major forms
of protein fatty-acylation, N-myristoylation and S-palmitoylation, in mammalian cells.
First, we established that fatty acid chemical reporters, combined with improved
bioorthogonal labeling conditions using CuAAC, enables specific and sensitive
fluorescent detection of protein myristoylation and palmitoylation. We further extended
this approach to enable tandem fluorescent detection of two protein modifications on
proteins of interest and showed that this tandem imaging method can be used to
efficiently monitor dynamic protein palmitoylation in cells.
I have shown that sensitivity of the bioorthogonal labeling approach enables
robust detection of endogenously expressed fatty-acylated proteins within minutes after
gel electrophoresis compared to days or weeks with radioactive analogues. Furthermore,
in-gel fluorescence detection of fatty-acylated proteins circumvents the need to transfer
proteins onto membranes for immunoblotting, which can be problematic for hydrophobic
polypeptides, and thus provides a more direct and quantitative means to detect protein
fatty-acylation as well as measure palmitoylation dynamics in cells. These significant
improvements in the detection of protein fatty-acylation offer new opportunities to
interrogate the functions and regulatory mechanisms of protein fatty-acylation, in
physiology and disease.
There are caveats to the bioorthogonal labeling approach described in this chapter.
First, it is likely that the fatty acid chemical reporters might be metabolized into longer or
shorter fatty acids such as acetate and be non-specifically installed onto proteins. While
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this is not evident from the fact that the myristate and palmitate analogs preferentially
label myristoylated and palmitoylated proteins respectively and do not label p53, an
acetylated protein (see Fig. 2.4), crosstalk between different fatty acid pools in the cell
can be reduced by minimizing metabolic labeling times. Second, most likely due to low
incorporation efficiency of the AHA methionine surrogate into proteins cells, we were
unable to detect AHA labeling of endogenous proteins and detection was possible only
upon overexpression. As a result, non-myristoylated proteins like H-Ras will have to be
overexpressed for us to measure palmitate turnover rates using the tandem detection
method (see Fig. 2.13). This problem may be circumvented by the use of other chemical
reporters for protein synthesis that are more efficiently incorporated into proteins.
Application of our new tools revealed accelerated palmitate cycling of Lck upon
T-cell stimulation, which raises several interesting questions. Studies demonstrate that
Lck palmitoylation is required for proper T-cell activation by targeting Lck to the plasma
membrane and maintaining its lipid raft association122, 123. Nonetheless, the physiological
consequences of increased palmitate cycling rate during cellular stimulation is unclear.
Live cell imaging studies suggest that Lck is dynamically recruited and distributed to the
periphery of immunological synapses during cellular activation33. It is therefore possible
that increased palmitate turnover upon T-cell activation serves to limit the proportion of
raft-associated Lck and its access to downstream substrates or activators. Notably,
accelerated palmitate turnover upon cellular stimulation have also been observed for
other proteins including G-protein coupled receptors and neuronal scaffold PSD9539, 53-55,
although how palmitate cycling on these proteins is modulated to be determined. For Lck,
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it is possible that protein thioesterase activity is stimulated by downstream effects of TCR
signaling such as release of calcium from intracellular stores in the ER. Alternatively,
activated and phosphorylated Lck may assume a conformational change favorable
towards spontaneous or enzymatic deacylation. Since protein thioesterases with
depalmitoylating activity towards Lck are yet to be identified, mechanistic insights into
the regulation of activity-induced palmitate turnover remain elusive.
To understand basic control mechanisms of protein palmitoylation, I was
motivated to use the genetically amendable fission yeast as a model because of its
relatively simple palmitoylation machinery compared to metazoans. This transition to
fission yeast will be further developed in the next chapter.
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Materials and Methods
Cell culture growth. Jurkat (human T-cell lymphoma) cells were propagated in RMPI
1640 supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 µg/mL
streptomycin in a humidified CO2 incubator at 37 ºC. Cell densities were maintained
between 1 x 105 and 2 x 106 cells per mL. HeLa cells were cultured in DMEM,
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin with 100 µg/mL
streptomycin and maintained in a humidified 37 °C incubator with 5% CO2.

Transfection of wild type, G2A, C3,6S Fyn constructs and HA-tagged H-RasG12V. For
transfection studies, HeLa cells were grown in a 10 cm culture plate supplemented with
DMEM containing 10% fetal bovine serum in a humidified CO2 incubator to
approximately 90% confluence before transfection with 12-15 µ g of DNA using
Lipofectamine 2000 (Invitrogen). The human Fyn constructs, wild-type and mutant Fyn
cDNAs cloned into eukaryotic expression vector pCMV5 as well as N-terminal HAtagged H-RasG12V (PCNC10) construct were kindly provided by Dr. Marilyn Resh
(Memorial Sloan-Kettering Cancer Center). Cells were transfected about 16 hours prior
to metabolic or pulse-chase labeling.

Metabolic labeling with fatty acid chemical reporters. Jurkat and HeLa cells were
treated for 2 hours with 20 µ M az-12, az-15, alk-12, alk-14 or alk-16 (50 mM DMSO
stock solutions) using the corresponding media for the respective cell types in the
humidified CO2 incubator at 37 ºC. The same volume of DMSO was used in the negative
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control. Following metabolic labeling, cells were harvested, washed once with ice-cold
PBS and pelleted at 1000 g for 5 min. Cells were directly lysed or flash frozen in liquid
nitrogen and stored at -80 °C prior to lysis. No significant loss of signal was observed for
frozen cell pellets.

Pulse-Chase labeling. Jurkat T-cells were labeled with 20 µM az-12 and 20 µM alk-16 in
RMPI 1640 supplemented with 2% charcoal-filtered fetal bovine serum, 100 U/mL
penicillin and 100 µg/mL streptomycin. For H-Ras studies, transfected HeLa cells were
incubated with 1 mM azidohomoalanine (AHA) and 20 µ M alk-16 in methonine-free
DMEM (Invitrogen) supplemented with 2% charcoal-filtered fetal bovine serum. The
same volume of DMSO was used in the negative controls. After 2 hours or 30 minutes
incubation, the labeled cells were chased with pre-warmed RMPI 1640 or DMEM
containing 200 µ M palmitate, 10% fetal bovine serum and/or 100 U/mL penicillin and
100 µg/mL. 100 µ M 2-bromopalmitate (2BP) (Fluka), 20 µ M (MAFP) (Sigma) or 200
µM phenylmethylsulfonyl fluoride (PMSF) were added to the chase medium to
investigate the effects of small molecule inhibitors on palmitate turnover. To determine
palmitate turnover upon T-cell activation, 100 mM pervanadate, freshly prepared by
dissolving sodium orthovanadate in 300 mM H2O2, was added to the chase medium for a
final pervanadate concentration of 0.1 mM. Samples were taken at various time points
during the chase, washed once with PBS and flash frozen in liquid nitrogen and stored at
-80 ºC prior to lysis.
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Preparation of cell lysates. Frozen Jurkat or HeLa cell pellets were lysed in chilled Brij
lysis buffer (1% Brij-97, 150 mM NaCl, 50 mM triethanolamine pH 7.4, 10× Roche
EDTA-free protease inhibitor cocktail, 10 mM PMSF) with vigorous vortexing (3 x 20 s),
placing tubes on ice during intervals to avoid heating of samples. For analysis of protein
phosphorylation after T-cell stimulation, 1:50 dilution of phosphatase inhibitor cocktail 2
(Sigma) was included in the lysis buffer. Lysates were spun at 1,000 g for 5 minutes at
room temperature to remove cellular debris. Typical lysate concentrations of 4-8 mg/ml
were obtained, as quantified using the BCA assay (Pierce).

Lysate CuAAC / click chemistry. Cell lysates (50 µg) in 44.5 µL RIPA lysis buffer were
reacted with 5.5 µL freshly premixed click chemistry reaction cocktail [azido- or alkynyldetection tag (100 µM, 5 mM stock solution in DMSO), tris(2-carboxyethyl)phosphine
hydrochloride (TCEP) (1 mM, 50 mM freshly prepared stock solution in deionized
water), tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (100 µM, 2 mM stock
solution in 1:4 DMSO:t-butanol) and CuSO4·5H2O (1 mM, 50 mM freshly prepared stock
solution in deionized water)] for a total reaction volume of 50 µL for 1 h at room
temperature. The reactions were terminated by the addition of ice-cold methanol (1 mL),
placed at −80 °C overnight and centrifuged at 18000g for 10 min at 4 °C to precipitate
proteins. The supernatant from the samples was discarded. The protein pellets were
allowed to air-dry for 10 min, resuspended in 25 µL of SDS buffer (4% SDS, 50 mM
triethanolamine pH 7.4, 150 mM NaCl). 8.7 µL 4×LDS sample buffer (Invitrogen) and
1.3 µL 2-mercaptoethanol were then added and the samples were heated for 5 min at 95
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°C; 20 µL of the sample was loaded per gel lane for separation by SDS-PAGE (4−20%
Bio-Rad Criterion Tris-HCl gel).

Immunoprecipitation-CuAAC. LAT, Lck and Ras proteins were immunoprecipitated
from 200 µg Jurkat cell lysate using the following antibodies at recommended
concentrations: mouse anti-Lck (p56lck) monoclonal (Clone 3A5, Thermo Scientific), rat
anti-v-H-ras (Ab-1) monoclonal (Y13-259 agarose conjugate, Calbiochem), and rabbit
anti-LAT polyclonal (Upstate). A rabbit anti-Fyn polyclonal (Upstate) was used to
immunoprecipitate wild-type and mutant Fyn proteins HeLa cell lysates. Upon incubation
at 4 °C for an hour with 25 µL of packed protein A-agarose beads (Roche) with an endover-end rotator (Barnstead/Thermolyne), the beads were washed three times with icecold RIPA lysis buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 mM
Tris pH 7.4, 150 mM NaCl). The beads were resuspended in 20 µL of resuspension buffer
(4% SDS, 50 mM triethanolamine pH 7.4, 150 mM NaCl) and 2.25 µL freshly premixed
click chemistry reagents (same as above) were added. After 1 hour at room temperature,
the reaction mixture was diluted with 8.7 µL 4× LDS sample buffer and 1.3 µL 2mercaptoethanol and separated by SDS-PAGE. A separate gel was loaded for Western
blot analysis.

Sequential on-bead CuAAC. Lck and Fyn proteins were immunoprecipitated from 0.6-1
mg of Jurkat cell lysate using antibodies described above. For HA-tagged H-RasG12V
immunoprecipitation, 15 µ L of anti-HA beads (Monoclonal anti-HA agarose conjugate,
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clone HA-7) was added to 200-300 µg of HeLa cell lysates. After 2 hours incubation on a
platform rocker at 4 °C, the beads were washed three times with 1 mL of ice-cold RIPA
buffer. The beads were resuspended in 20 µ L of PBS and 2.25 µL freshly premixed azrho click chemistry reaction cocktail described above for a total approximate reaction
volume of 25 µL for 1 hour at room temperature. The beads were washed three times with
1mL of ice-cold RIPA buffer and resuspended in 20 µL of SDS buffer. For the second
CuAAC reaction, 2.25 µL of freshly premixed click chemistry reagents (alk-Cyfur in
place of az-rho) were added. After 1 hour at room temperature, the reaction mixture was
diluted with 8.7 µL 4× LDS sample buffer and 1.3 µL 2-mercaptoethanol, heated for 5
min at 95 °C, and 20 µL was loaded per gel lane for separation by SDS-PAGE. A separate
gel was loaded for Western blot analysis.

In-gel fluorescence scanning. Proteins separated by SDS-PAGE were visualized by
incubating the gel in 40% methanol, 10% acetic acid for at least 1 hour and directly
scanning it on a GE healthcare Typhoon 9400 variable mode imager. Rhodamineassociated signal was detected at excitation 532 nm/emission 580 nm while orthogonal
detection of Cyfur-associated signal was achieved at excitation 633 nm/emission 670 nm.

In-gel hydroxylamine treatment. After an initial fluorescence scan to determine
pretreatment fluorescence, the gel was rinsed with deionized water and soaked in freshly
prepared 1 M hydroxylamine (pH 7.4) for 2 hours at room temperature on a shaker. The
gel was subsequently rinsed with deionized water and incubated with shaking for 2 hours
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in 40% methanol, 10% acetic acid at room temperature prior to scanning for posttreatment fluorescence.

Western blots. Proteins separated by SDS-PAGE were transferred to nitrocellulose
membranes (50 mM Tris, 40 mM glycine, 0.0375% SDS, 20% MeOH in deionized water,
Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 40 min), which were blocked with 10% non-fat
milk, 5% BSA, 0.1% Tween-20 in PBS (0.1% PBST) and washed with 0.1% PBST
before incubation with appropriate antibodies. Membranes were incubated with a mouse
anti-Lck (p56Lck) monoclonal (Clone 3A5, Invitrogen) followed by light chain-specific
HRP-conjugated affiniPure goat anti-mouse secondary (Jackson Immunoresearch
Laboratories) for anti-Lck blots. Likewise, anti-Fyn and anti-LAT blots were treated with
mouse anti-Fyn monoclonal (S1, Chemicon) and mouse anti-LAT monclonal (2E9,
Upstate) respectively and followed by goat anti-mouse HRP-conjugated secondary
antibody (Upstate). Anti-HA blots were treated with rabbit anti-HA polyclonal
(CloneTech) followed by goat anti-rabbit HRP-conjugated secondary antibody (Upstate).
Anti-phosphotyrosine blots were blocked with 5% BSA, 0.1% PBST prior to incubation
with HRP-conjugated anti-phosphotyrosine mouse monoclonal (PY99, Santa Cruz). Blots
were developed using the enhanced chemiluminescent kit (GE Healthcare).
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Image processing and calculations. All images were processed and analyzed using the
ImageJ software. A rectangular box was tightly selected around the band(s) of interest
and average fluorescence intensity at mid-length of the box was measured. Dimensions of
the box were maintained within the same experiment. No event of signal saturation was
observed in this study. Background signal from non-specific labeling was removed by
subtracting measurements of the DMSO sample from each of the data points. The ratio of
background-corrected alk-16 to az-12 associated fluorescent signals accounted for protein
load and turnover at each time point of a pulse-chase analysis. To allow comparison
between pulse-chase experiments, alk-16/az-12 values within each dataset were
normalized such that alk-16/az-12=1 at T=0 hours, which was defined as the earliest of
three consecutive time points during which a decrease of alk-16/az-12 was initially
observed. Since values obtained under some conditions tested did not form a straight line
when plotted on a logarithmic scale, which was observed by others (50), data for each
protein or chase condition was fitted to a two-phase exponential decay model using the
KaleidaGraph graphing and data analysis software. The equation used was a biphasic
exponential decay line m1*exp(-m2*m0)+m3*exp(-m4*m0), which starts at m1+m3 and
decays with rate constants m2 and m4. The half-life of protein-bound palmitate (t1/2) was
defined as the length time required for the normalized alk-16/az-12 signal to decrease
halve if decay was to occur solely at the initial rate, which is ln(2)/m2 with m1=0.5.
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CHAPTER 3
RHEOSTATIC CONTROL OF PROTEIN PALMITOYLATION REGULATES
MEIOTIC COMMITMENT IN FISSION YEAST

Introduction
With advancements in biochemical methods for the detection and identification of
palmitoylated proteins, including those described in Chapter 2, it is evident that reversible
protein palmitoylation is subjected to regulation in vivo at the level of individual proteins
as well as the level of the palmitoylomes. Changes in the protein palmitoylation states
and in the repertoire of modified proteins associated with different physiological states11,
39, 54, 56

hint at the potential of this lipid modification to be a major cellular regulator akin

to phosphorylation. Nonetheless, little is known of about how these changes are
coordinated with physiological states and how they affect cellular function.
The family of DHHC-containing PATs is known to be responsible for most protein
palmitoylation events and genes encoding PATs are found in all eukaryotes, ranging from
a handful in unicellular fungi to more than twenty in metazoa (Fig. 3.1a, b). The multiple
PATs in an organism raises intriguing questions about substrate specificity and regulation.
Specific PATs were found to have different subcellular locations and tissue-specific
distribution70, 71, suggesting the possibility that PATs play diverse roles in cells.
Nonetheless, understanding their roles in regulating global palmitoylation and cellular
physiology has been difficult due to extensive biochemical and functional overlap among
multiple PATs12, 67-69.
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Figure 3.1 | Model organisms used for PAT studies. a, Phylogenetic clustering of human and S.
cerevisiae (Red) DHHC-containing PATs based on ClustalX alignment of the 51 amino acid
DHHC core sequence. Six potential subfamilies (I-VI) are indicated by brackets. Adapted from
Mitchell et al.133 b, Model organisms used in PAT studies and the number of DHHC-containing
PATs encoded in each genome. Blue: S. pombe PATs have not been studied.

I chose to work in the fission yeast Schizosaccharomyces pombe because of its
simple palmitoylation machinery compared to other model organisms that are
traditionally used in PAT studies (Fig. 3.1b). Like the budding yeast Saccharomyces
cerevisiae, S. pombe is genetically amendable and has proven to be a useful model for
fundamental principles and mechanisms such as cell cycle control, genome organization
and signal transduction. Although studies of S. pombe PATs have not been reported, its
simple PAT network should facilitate the functional dissection of individual PATs. A study
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on compartmentalized Ras signaling provided further motivation to move into fission
yeast. Onken et al. showed that the only Ras protein in S. pombe, Ras1, controls cell
morphology and mating depending on its subcellular location, which in turn depends on
its palmitoylation state28. The combination of a simple PAT network and a highly
conserved protein substrate with distinct palmitoylation-dependent outputs that are easily
scored make S. pombe an attractive model to study basic control mechanisms of protein
palmitoylation.
In this chapter, I showed that the chemical tools that we have previously
developed in mammalian cells also works in fission yeast. Combining chemical and
genetic approaches, I showed that physiological control of PAT levels underlies
differential modification of its cognate substrates in distinct cellular states, shaping the
palmitoylome, which in turn plays a critical role in meiotic commitment. Based on these
results, I propose that rheostatic control of single or multiple PAT activities quantitatively
regulates global protein palmitoylation, which can have important consequences on
cellular events.
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Results
S. pombe has a simplified PAT network
In contrast to metazoa and budding yeast, where high functional redundancy among
multiple PATs has been reported68, 69, the fission yeast genome contains only five open
reading frames that encode proteins containing the conserved DHHC motif preceded by a
cysteine-rich domain, which is a characteristic feature of PATs (Fig. 3.2a). This less
complex PAT network allows me to more easily dissect the functional contribution and
regulation of individual PATs.

Figure 3.2 | DHHC-PATs in S. pombe. a, Partial sequence alignments and consensus sequence
of the five DHHC-containing PATs encoded in the S. pombe genome. Viability of null mutants are
also indicated. b, Growth and morphological phenotypes of cells with individual PAT deletions.
Notably, erf2∆ and erf4∆ cells are viable at 32 °C and 34 °C but inviable at 36 °C. DIC images
(Top panel) as well as measurements of cell lengths (n=20) at division and generation times
(Bottom panel) of indicated strains.
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Of the five PATs, only Swf1 was essential for viability134 while deletions of the
remaining PATs had no effect on cell growth or morphology under exponential vegetative
growth conditions at 32 °C. (Fig. 3.2). Notably, erf2∆ and erf4∆ cells are inviable at 36
°C. I focused on the Erf2 PAT and its accessory protein Erf4, whose roles in meiosis are
suggested by their strongly regulated expression during this major transitional event in
fission yeast135, 136. This system, where PAT regulation is linked to a highly coordinated
biological process, provides a good model to study how regulation of PATs affects global
protein palmitoylation and its functional consequences.

Erf2 PAT function regulates meiosis in S. pombe
Fission yeast cells proliferate in the haploid state but when nutrients become limiting,
cells of opposite mating types conjugate to form a diploid zygote. These diploid cells
replicate their genome and then undergo two successive nuclear divisions to yield four
haploid nuclei that mature into spores, completing meiosis (Fig. 3.3a). To specifically
investigate a potential role for Erf2 in meiosis as well as circumvent the mating defect of
haploid erf2Δ cells (Fig. 3.6c), I constructed stable diploids containing a temperaturesensitive allele of the Pat1 meiotic repressor, pat1-114, which can be used to
synchronously induce meiosis137-139 (Fig 3.4a). Consistent with genome-wide expression
studies135,

136,

transcript levels of erf2 and erf4 were significantly upregulated in

synchronized meiotic cells compared to vegetative cells (Fig. 3.3b). Expression of erf2
and erf4 was also induced by overproduction of the meiosis-specific Mei4 transcription
factor (Fig. 3.3c). Compared to erf2+ cells, erf2Δ mutants were delayed in meiotic entry,
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as determined by the onset of S phase (Fig. 3.4b), and in meiotic progression (Fig. 3.4c,
d). The striking increase in the length of erf2Δ cells suggests that they continued
vegetative growth during this delay (Fig. 3.4d). Taken together, these observations
indicate a role for Erf2 in regulating meiotic entry, suggesting that changes in global
protein palmitoylation are critical determinants in meiotic commitment.

Figure 3.3 | erf2 and erf4 expression are strongly regulated during meiosis in fission yeast. a,
Schematic representation of the fission yeast sexual differentiation process. Haploid cells
conjugate to form a diploid zygote, which undergoes meiosis to yield four haploid nuclei that
matures into spores. b, qPCR analysis of erf2 and erf4 transcripts in vegetative (Veg) and meiotic
(Mei, 8 h after meiotic induction) pat1-114/pat1-114 cells. c, qPCR analysis of indicated
transcripts in vegetative haploid cells overexpressing (OE) Mei4 from a thiamine-repressible
promoter. Fold change, transcript levels after 24 hours in thiamine-free medium compared to that
in thiamine-containing medium. mde5 is a known Mei4 target gene. b, c, All transcript levels
were normalized to act1 mRNA. Error bars, s.d.
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Figure 3.4 | erf2Δ cells are delayed in meiotic entry. a, Pat1 is repressor of meiosis.
Synchronous meiosis in diploid pat1-114/pat1-114 cells was induced by shifting nitrogen-starved
cultures to restrictive temperature (see Methods). b, DNA content analysis of indicated strains
after meiotic induction. c, d, Percentage of cells with 1, 2 or >2 nuclei were determined by
counting ≥ 200 DAPI-stained cells of the indicated strains at hourly intervals after meiotic
induction (left panel). Shaded area facilitates comparison between the two strains. Representative
DIC (middle panel) and DAPI (right panel) images of cells at indicated times after temperature
shift. Scale bars, 10 µm.
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Chemical tools also work in fission yeast
To assess Erf2-dependent modulation of the palmitoylome during meiosis, we employed
the alkyne-functionalized palmitate chemical reporter described in Chapter 2, alk-16140,
together with bioorthogonal labeling (Fig. 3.5a), which allows superior fluorescent
detection of the modification compared to conventional radiolabeled lipids in mammalian
and yeast cells (Fig. 3.5b-d). This bipartite bioorthogonal labeling approach enabled
robust visualization of global and individual palmitoylated proteins such as Ras1 without
overexpression (Fig. 3.5b). Alk-16 labeling of Ras1 was competed away by palmitic acid
in a dose-dependent manner (Fig. 3.5c). Additionally, preincubating cells with broadspectrum palmitoylation inhibitor 2-bromopalmitate or post-CuAAC cleavage of
thioesters with hydroxylamine greatly diminished the fluorescence signal observed for
Ras1 (Fig. 3.5d). In contrast, pretreating cells with protein synthesis inhibitor
cycloheximide had minimal effect on Ras1 labeling (Fig. 3.5d). Collectively, these
experiments established alk-16 as a specific and robust reporter for post-translational
protein S-palmitoylation in fission yeast at endogenous substrate and enzyme
concentrations.
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Figure 3.5 | Chemical tools work in fission yeast. a, Schematic representation of the
bioorthogonal detection protocol. Alk-16: alkyne-functionalized palmitate reporter. Az-rho: azidefunctionalized rhodamine fluorophore. CuAAC: copper-catalyzed azide-alkyne cycloaddition. b,
In-gel fluorescent detection of alk-16 labeled proteins in lysates and immunopurified Ras1. c, d,
Fluorescent detection of immunopurified Ras1, a known palmitoylated protein, from alk-16
labeled cells (top panels). Western blots are probed for Ras1 (bottom panels). Palmitate (Palm)
competes with alk-16 labeling in a dose-dependent manner. Ras1 fluorescence signal was greatly
diminished by preincubating cells with a general palmitoylation inhibitor 2-bromopalmitate (2BP)
or by post-CuAAC cleavage of palmitoylation thioester linkages with hydroxylamine (NH2OH).
Pretreatment of cells with the protein synthesis inhibitor cycloheximide (CHX) had little effect on
post-translational Ras1 labeling by alk-16.
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Ras1 is a substrate of the Erf2-Erf4 PAT complex
Using this system, I showed that the Erf2-Erf4 PAT complex and not two of the other
putative PATs is required for the incorporation of alk-16 onto Ras1 (Fig. 3.6a), a known
palmitoylated protein whose modification has been implicated in pheromone signaling28.
Incorporation of alk-16 directly requires Erf2 PAT activity as re-introduction of Erf2, but
not a catalytically inactive DHHC➞DHHA mutant58, 62, rescued the Ras1 palmitoylation
defect in erf2Δ cells (Fig. 3.6b). Since palmitoylation of Ras1 has been implicated in
pheromone signaling28, these observations are consistent with the mating defect of erf2Δ
cells (Fig. 3.6c). Akr1 may substitute for Erf2 function since deletion of akr1 in an erf2Δ
background further decreased mating efficiency although no mating defect was observed
for akr1Δ cells. This is not surprising given the redundancy between the multiple budding
yeast and mammalian PATs68, 69. Collectively, these experiments demonstrate that Erf2Erf4 is able to specifically incorporate alk-16 into its substrates and that this method can
be used to profile Erf2 substrates.
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Figure 3.6 | Ras1 is a substrate of the Erf2-Erf4 PAT complex. a, b, Alk-16-associated
fluorescence of immunopurified Ras1 from cells with the indicated PAT deletions (top panels).
Western blots are probed for Ras1 (bottom panels). Wild type (DHHC) or catalytic inactive
(DHHA) Erf2 was expressed from a thiamine-repressible promoter in erf2Δ cells. c, erf2Δ and
erf4Δ cells are defective in mating. Mating efficiency is quantified as the percentage of diploid
zygotes/spore-containing asci after 2 days in nitrogen-free medium normalized to wild type
(n≥200). Error bars, s.d.
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Erf2 drives changes in the palmitoylome during meiosis
The significantly elevated erf2 transcript levels in meiotic cells and the phenotypes of
erf2Δ cells support its role in orchestrating meiosis-specific protein palmitoylation (Fig.
3.3). To determine whether increased erf2 expression alone has an impact on the meiotic
palmitoylome, I profiled palmitoylated proteins by in-gel fluorescence in diploid cells
undergoing synchronous meiosis. A distinct meiotic palmitoylome with a prominent band
at approximately 23 kDa is established following the striking increase in Erf2 protein
levels (Fig. 3.7a), which reflects the reported erf2 transcription profile during meiosis135,
136.

This specific palmitoylome requires Erf2 activity, as modification of those prominent

substrates was not observed in either erf2Δ or erf4Δ cells undergoing meiosis (Fig. 3.7b,
c). Ras1 was also palmitoylated in an Erf2-Erf4 dependent manner in meiotic cells (Fig.
3.7c, lower panel), suggesting a role for Ras1 in meiosis141. Since the salient features of
the meiotic palmitoylome were still observed when two of the other putative PATs are
deleted (Fig. 3.7c), I concluded that Erf2 is the primary PAT driving changes in the
protein palmitoylation during meiosis.
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Figure 3.7 | The Erf2-Erf4 PAT is required for meiotic-specific protein palmitoylation. a, b,
Fluorescence profiles of palmitoylated substrates in erf2-HA3/erf2-HA3 pat1-114/pat1-114 and
erf2∆/erf2∆ pat1-114/pat1-114 cells undergoing synchronized meiosis (top panels). At the
indicated times after meiotic induction, aliquots of the culture were pulse-labeled with alk-16.
Western blots were probed for tubulin and HA (middle and bottom panels). c, Fluorescence
detection of palmitoylated substrates (top panel) and Ras1 palmitoylation (bottom panel) in
homozygous diploid pat1-114/pat1-114 cells with the indicated PAT deletions 8 h after meiotic
induction. (-): DMSO control. Veg: vegetative cells. Red arrowhead points to the major substrate
~25 kDa that is specifically modified by Erf2 in meiotic cells.
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Isp3 and Rho3 are selectively palmitoylated by Erf2 in meiotic cells
To identify the major Erf2 substrates that are preferentially palmitoylated during meiosis,
I affinity purified alk-16 labeled proteins in meiotic erf2+, vegetative erf2+, and meiotic
erf2Δ cells using a cleavable azido-biotin tag (Supplementary Fig. 3.8a, b). Recovered
proteins were subsequently identified by gel-based proteomics, and those with ≥ 2-fold
spectral counts in alk-16 samples compared to the corresponding DMSO controls were
further studied. Proteins enriched in meiotic erf2+ cells were subjected to two filter
criteria, excluding those also enriched in (1) meiotic erf2Δ cells and (2) vegetative erf2+
cells (Fig. 3.8c). Notably, Ras1 was excluded by the second filter because it was equally
recovered in both meiotic and vegetative erf2+ cells, consistent with the biochemical
analyses (Fig. 3.9d). Of the 238 remaining candidates (Appendix 1), we focused on Isp3
and Rho3 (Fig. 3.8e) as they were the most highly enriched proteins with molecular
weights matching the prominent ~23 kDa band we previously observed (Fig. 3.8d).
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Figure 3.8 | Identification of Erf2 substrates that are selectively palmitoylated during
meiosis. a, Schematic representation of the selective enrichment protocol of alk-16 modified
proteins from cell lysates using streptavidin beads. Az-azo-biotin: Azide-functionalized biotin
probe with an azobenzene cleavable linker. CuAAC: copper-catalyzed azide-alkyne
cycloaddition. b, c, Filter criteria for candidate substrates that are palmitoylated by Erf2 during
meiosis. d, Each of the 238 candidates from (c) is represented as a data point reflecting its
molecular weight and enrichment (net spectral counts) in alk-16 over DMSO labeled erf2+
meiotic cells. Isp3 and Rho3 are the top two candidates with molecular weights ~23 kDa
(shaded). e, Amino acid sequences of Rho3 and Isp3, both of which were validated to be Erf2
substrates that are selectively palmitoylated in meiotic cells. Yellow: identified peptides. Green:
modified amino acids in identified peptides (e.g. oxidation, carbamidomethylation).
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Cognate Erf2 substrates are differentially modified in distinct cellular states
Isp3, an abundant spore protein specifically expressed in meiotic cells142 (Fig. 3.9c), was
the most heavily modified species since the ~23 kDa band was lost in isp3Δ cells and
HA3-tagging of Isp3 reduced the electrophoretic mobility of the major fluorescent band
(Fig. 3.9a). I also confirmed that Rho3, a Rho GTPase involved in polarized growth143, is
an Erf2 substrate (Fig. 3.9b) that is differentially modified with between meiotic and
vegetative cells (Fig. 3.9d). This suggests a mechanism by which changes in the
palmitoylome can be mediated by the regulation of a single PAT (Fig. 3.9e). Given that
Erf2 expression is low in vegetative cells and high in meiotic cells, I reasoned that the
differential modification of Erf2 substrates could be a consequence of PAT levels.
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Figure 3.9 | Erf2 substrates are differentially modified in vegetative and meiotic cells. a,
Fluorescence profiles of meiotic cells with indicated gene deletions or those expressing
endogenous or tagged Isp3 (top panels). Control: isp3+ cells labeled with DMSO instead of
alk-16. Bottom panels: Coomassie or western blot probed for HA. b, Palmitoylation of Rho3-HA3
in meiotic erf2+ and erf2Δ cells (top panel). Western blot is probed for HA (bottom panel). c,
Isp3-HA3 expression as determined by anti-HA blot of lysates from cells in indicated cellular
states. Veg: vegetative cells. Mei: meiotic cells. d, Rho3 and Ras1 palmitoylation states in
vegetative and meiotic cells (top panels). Western blots were probed for Ras1 or HA (bottom
panels). a-d, Synchronous meiosis in indicated diploid pat1-114/pat1-114 cells was induced by
shifting nitrogen-starved cultures to restrictive temperature (see Methods). Meiotic cells refer to
cells 8 h after the temperature shift. e, While differential palmitoylation of Isp3 in meiotic and
vegetative cells can be explained by meiosis-specific isp3 expression, the differential
modification of Ras1 and Rho3 is mediated by an alternative mechanism. Yellow circles represent
palmitoylation of the indicated Erf2 substrates.
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Erf2-Erf4 PAT levels shape the meiotic palmitoylome
To test this hypothesis, I reduced erf2 expression in diploid cells undergoing
synchronized meiosis, achieving intermediate and low expression relative to wild type
(Fig. 3.10a, top). Although all three substrates require Erf2 for palmitoylation, Ras1,
Rho3 and Isp3 were differentially modified as a consequence of altering erf2 levels (Fig.
3.10a). Ras1 was efficiently palmitoylated at low erf2 expression levels, and its
palmitoylation was unaltered at higher levels. In contrast, reducing erf2 expression
decreased Rho3 and Isp3 palmitoylation with different sensitivities. This demonstrates
that modulation of PAT levels can differentially alter the palmitoylation of individual
substrates and suggests that the strong upregulation of erf2 expression during meiosis is
needed to establish the distinctive features of the meiotic palmitoylome.
If physiological control of Erf2-Erf4 abundance solely accounts for the
palmitoylome changes observed upon meiosis, it is predicted that increasing Erf2-Erf4
levels in haploid vegetative cells would yield a palmitoylome similar to that of meiotic
cells. To test this, I focused on Ras1 and Rho3 as model substrates since isp3 expression
is restricted to meiotic cells (Fig. 3.9c). Ras1 palmitoylation was insensitive to increases
in Erf2-Erf4 levels (Fig. 3.10b), consistent with our results in meiotic cells. In contrast,
while individual overexpression of erf2 and erf4 had no impact on Rho3 modification, a
striking increase in Rho3 palmitoylation was observed when the effective Erf2-Erf4 PAT
concentration was increased by co-overexpression of erf2 and erf4 (Fig. 3.10b, strains
4-7). Intermediate overproduction of Erf2-Erf4 resulted in a modest increase in Rho3
palmitoylation, indicating a dose-dependent function of PAT activity (Fig. 3.10b, strain
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8). Importantly, although erf2 and erf4 were expressed from heterologous promoters,
their levels were in fact within physiological range, with the highest and lowest levels
being comparable to those attained by meiotic and vegetative cells respectively (Fig. 3.3b
and 3.10a, b). These results demonstrate that rheostatic control of protein palmitoylation
by varying PAT levels is a mechanism by which cells finely shape the palmitoylome and
that this may play a key role in cellular transitions such as meiosis.
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Figure 3.10 | Physiological changes in Erf2-Erf4 levels underlie the differential modification of
cognate substrates in meiotic and vegetative cells. a, Labels are indicated in box. qPCR analysis of erf2
and erf4 transcripts normalized to act1 mRNA levels in indicated pat1-114/pat1-114 strains 8 h into
synchronous meiosis (top panel). Error bars, s.d. Palmitoylation of cognate Erf2 substrates were analyzed
from the same lysate of each strain (bottom panels). Ras1 and Rho3-HA3 were immunopurified and their
levels were determined by Ras1 and HA immunoblots respectively. Isp3 palmitoylation was monitored at
the lysate level since it accounts for most of the fluorescence at ~23 kDa (Isp3 is unstable upon
immunoprecipitation, data not shown). b, Labels are indicated in box. Overexpression of erf2 and/or erf4
from thiamine-repressible nmt promoters in the indicated vegetative pat1-114 cells was achieved by
switching them into thiamine-free medium for 24 h. qPCR analysis (top panel) as well as palmitoylation of
Ras1 and Rho3 (bottom panels) were performed as described in (a). Isp3 is not expressed in vegetative
cells.Cells were maintained at permissive temperature throughout this experiment (See Methods). c, DAPI
(left) and DIC (right) images of indicated cells 96 h after erf2 and/or erf4 overexpression. Strain 7*: nmt1erf2 (DHHA) nmt1-erf4. Scale bars, 10 µm.
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Erf2-Erf4 overproduction is sufficient to induce a meiotic phenotype in vegetative cells
If PAT-mediated changes in global protein palmitoylation are critical in meiotic entry,
then increasing Erf2-Erf4 levels in vegetative cells may be sufficient to trigger meiosis in
the absence of nutritional cues. Strikingly, overexpression of erf2 and erf4 in proliferating
haploid cells induced a meiotic phenotype (Fig. 3.10c, strain 7). A significant reduction in
growth rate with time, accompanied by a reduction in cell length at division and a
transient G1 delay (Fig. 3.11a-c) was observed. At 96 hours after induction, a significant
proportion of cells had >2 nuclei (Fig. 3.11d). These cells were appeared to be
undergoing a meiotic program since deletion of mei4, which is required for meiotic but
not mitotic divisions, resulted in the disappearance of cells with >2 nuclei and
accumulation of misshapen cells with a single nucleus (Fig. 3.11f). The appearance of
spores that are resistant to β-glucuronidase digestion, which specifically kills vegetative
cells further suggested that these cells were indeed undergoing sexual differentiation
program (Fig. 3.11e). While Erf2-induced haploid meiosis produced mainly inviable
spores, overexpression erf2 and erf4 in diploid cells also induced a meiotic phenotype
and yielded viable spores (Fig. 3.13). Under these same conditions, non-overexpressing
cells continued normal vegetative growth over the course of the experiment (Fig. 3.12).
Overall, these results demonstrate that increasing the levels of a single PAT activity is
sufficient to induce sexual differentiation in otherwise proliferating cells and implicate
the control Erf2-Erf4 activity levels as a major determinant in S. pombe meiotic
commitment.
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Figure 3.11 | Overproduction of Erf2 and Erf4 in proliferating cells induce a meiotic
phenotype. a-e, erf2 OE erf4 OE: strain 7 from Fig. 3.10 that co-overexpresses erf2 and erf4 at
high levels. These cells were grown in the presence of nutrients at permissive temperature, and
co-overexpression of erf2 and erf4 was induced by switching cells to thiamine-free medium (See
Methods). Indicated times or time intervals refers to time after induction of erf2 and erf4 cooverexpression. a, Fold change in OD595 of cultures during indicated 12 h intervals. OD595 was
maintained < 0.6 (See Methods). b, DNA content analysis. c, Blankophor staining of cells (top
panels). Dimensions of septated cells (cell length and width, n=20) and percentage of septated
cells (septation index, n≥200) were determined by measuring and counting blankophor-stained
cells (bottom panels, left to right). Error bars, s.d. d, Percentage of cells with 1, 2 or >2 nuclei
(n≥200) was determined by DAPI staining. e, Left panel, percentage of cells with spores (n≥200)
at indicated times post-induction. Right panel, DIC images of cells 96 h post-induction before and
after β -glucuronidase digestion, which specifically kills vegetative cells but not spores. f, DAPI
(top) and DIC (bottom) images of indicated erf2 and erf4 co-overexpressing cells 96 h postinduction. Scale bars, 10 µm.
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Figure 3.12 | Non-overexpressing pat1-114 cells continue vegetative growth under the same
conditions. erf2 OE erf4 OE: strain 7 from Fig. 3.10 that co-overexpresses erf2 and erf4 at high
levels. erf2 erf4: strain 4 from Fig. 3.10 that expresses erf2 and erf4 at endogenous levels. These
cells were grown in the presence of nutrients at permissive temperature, and co-overexpression of
erf2 and erf4 was induced by switching cells to thiamine-free medium (See Methods). Indicated
times or time intervals refers to time after the switch to thiamine-free medium. a, Fold change in
OD595 of cultures during indicated 12 h intervals. OD595 was maintained < 0.6 (See Methods). b,
DNA content analysis. c, Blankophor staining of cells (left panels).Scale bars, 10 µm. Dimensions
of septated cells (cell length and width, n=20, middle panels) and percentage of septated cells
(septation index, n≥200, right panel) were determined by measuring and counting blankophorstained cells. Error bars, s.d. d, Percentage of cells with 1, 2 or >2 nuclei (n≥200) was determined
by DAPI staining of the indicated strains. e, Percentage of cells with spores at indicated times
post-induction (n≥200).
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Figure 3.13 | Ectopic meiosis in diploid cells co-overexpressing erf2 and erf4 yields viable
spores. Strain 7 from Fig. 3.10 was diploidized and grown in the presence of nutrients at
permissive temperature, and co-overexpression of erf2 and erf4 was induced by switching cells to
thiamine-free medium (See Methods). Indicated times or time intervals refers to time after the
switch to thiamine-free medium. a, Fold change in OD595 of cultures during indicated 12 h
intervals. OD595 was maintained < 0.6 (See Methods). b, DNA content analysis. c, Blankophor
staining of cells (top panels). Dimensions of septated cells (cell length and width, n=20) and
percentage of septated cells (septation index, n≥200) were determined by measuring and counting
blankophor-stained cells (bottom panels, left to right). Error bars, s.d. d, Percentage of cells with
1, 2 or >2 nuclei (n≥200) was determined by DAPI staining (left panel). DAPI and DIC images of
cells 96 h post-induction (right panels). e, DIC image of cells 96 h post-induction after βglucuronidase digestion, which specifically kills vegetative cells but not spores. f, Percentage of
cells with spores (n≥200). Viable colonies were obtained after plating β -glucuronidase digested
cells at 84 h and 96 h. Scale bars, 10 µm.
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Erf2-induced meiotic phenotype is dependent on PAT activity levels
Consistent with the rheostat model (Fig. 3.10), this meiotic phenotype was dependent on
high PAT levels, as cells continued vegetative growth when erf2 and erf4 are expressed at
low (Fig. 3.11f, +Thiamine) or intermediate levels (Fig. 3.10c, strain 8). Critically,
meiotic induction was not observed in cells co-overexpressing a catalytically inactive
Erf2 mutant and Erf4 (Fig. 3.10c, strain 7*) or in cells overproducing either Erf2 or Erf4
alone (Fig. 3.10c, strains 5 and 6), highlighting the requirement for a functional and
active PAT complex. Together with the meiotic delay observed in erf2Δ cells, these
results demonstrate that modulation of Erf2-Erf4 activity levels through changes in the
expression of each subunit is a key step for meiotic commitment.

Rho3 function is required for Erf2-induced meiosis
As erf2 and erf4 expression are upregulated in cells undergoing normal meiosis when
encountering low nitrogen conditions136, these results suggest that PAT level-mediated
modulation of the palmitoylome is a major determinant of meiotic entry. What are the
cellular factor(s) involved in this process? As meiosis can be induced by Erf2-Erf4
overproduction, I reasoned that Erf2-Erf4 substrates involved in triggering meiosis would
have to be present in vegetative cells and sensitive to Erf2-Erf4 levels for their
palmitoylation state (Fig. 3.14a). One such substrate is Rho3 (Fig. 3.9b, d, and 3.10b). I
found that Rho3, but not Ras1, is required for the meiotic phenotype triggered by Erf2Erf4 overexpression in haploid cells (Fig. 3.14b). This is clearly dependent on the Exo70
subunit of the exocyst complex and the Formin For3 (Fig. 3.14b), both effectors of Rho3,
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suggesting a novel role for Rho3 in meiotic control in fission yeast, potentially through
its function in polarized exocytosis that is likely to be regulated by its palmitoylation
state143, 144.

Figure 3.14 | A novel function of Rho3 in S. pombe meiotic control. a, As meiosis can be
induced by Erf2-Erf4 overproduction, the cellular factor(s) involved in Erf2-mediated meiotic
control should be present in vegetative cells. Yellow circles represent palmitoylation of the
indicated Erf2 substrates. b, DAPI (top) and DIC (bottom) images of erf2 and erf4 cooverexpressing cells with indicated deletions 96 h post-induction. Scale bars, 10 µm. Rho3 in S.
pombe regulates polarized cell growth through For3 and Exo70, both of which are required for
the observed meiotic phenotype. Rho3 has also been implicated in Golgi/endosome trafficking
through Apm1 but Apm1 function is not required for Erf2-Erf4 induced meiosis.

83

Erf2 function is required for proper Rho3 localization in vegetative and meiotic cells
Since palmitoylation has been shown to control protein function by changing protein
distribution between the plasma and intracellular membranes, in collaboration with Dr.
Pei-Yun Jenny Wu, we asked if Erf2-mediated palmitoylation of Rho3 affects its
subcellular localization during ectopic meiosis. While Rho3 normally localizes to cell tips
and septa in vegetative cells144, enhanced enrichment at cell tips was observed with Erf2Erf4 overexpression (Fig. 3.15a), which coincided with increased Rho3 palmitoylation
(Fig. 3.10b). Interestingly, Rho3 relocalized to what appeared to be prespore surfaces
encapsulating individual nuclei as cells completed meiosis (Fig. 3.15a). This
redistribution of Rho3 from cell tips to prespore surfaces was also observed under more
physiological conditions, during meiosis in diploid cells induced by Pat1 inactivation
after nitrogen starvation (Fig. 3.15b). Rho3 localization in both vegetative and meiotic
cells requires palmitoylation by Erf2 (Fig. 3.15c), which was also visualized at forespore
surfaces during meiosis (data not shown). Taken together, these data suggest that Erf2Erf4 regulates Rho3 function, and potentially its role in polarized exocytosis, by altering
its subcellular distribution.
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Figure 3.15 | Erf2-dependent Rho3
localization in vegetative and
meiotic cells. Immunofluorescence
localization of Rho3-HA3 and DAPI
images (left panels). Background
anti-HA immunofluorescence and
respective DAPI images (right
panels). Images are maximum
intensity projections. Scale bars, 10
µm. a, Haploid cells were grown in
the presence of nutrients at
permissive temperature. Cooverexpression of erf2 and erf4 (erf2
OE erf4 OE) was induced by
switching cells to thiamine-free
medium (See Methods). Indicated
times refers to time after the switch
to thiamine-free medium. b, c,
Meiosis in homozygous diploid
pat1-114/pat1-114 cells with the
indicated genotypes was induced by
shifting the culture to restrictive
temperature for the indicated times.
Later time points were taken for
erf2Δ cells to compensate for the
meiotic delay in these cells (Fig.
3.4).
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Summary and Discussion
In this chapter, we demonstrated that PAT levels matter. Physiological control of PAT
levels underlie the differential modification of distinct substrates in vegetative and
meiotic cells and palmitoylome changes mediated by control of the level of Erf2-Erf4
activity are sufficient to induce meiosis in fission yeast. We propose that rheostatic
control of single or multiple PAT activities quantitatively regulates palmitoylomes, which
we showed have important consequences on cellular events.
This study showcases fission yeast as a relevant and complementary model
organism for PAT studies. Consistent with studies in budding yeast and mammals12, 65, 67,
I showed that fission yeast PATs can have different substrate preferences and that specific
PAT-substrate pairs are needed for efficient palmitate transfer. Notably, the Erf2Erf4:Ras1 PAT:substrate pairing in fission yeast is reminiscent of the ERF2-ERF4:RAS1/
RAS2 and DHHC9-GCP16:H-/N-Ras pairs in budding yeast and human, respectively
59.

58,

This suggests an evolutionary selection for specific cognate PAT:substrate pairs, which

would be unlikely if PATs have extensive overlapping substrate preferences and were able
to freely substitute for each other. Furthermore, from the relatively few PAT paralogs in
fission yeast, I surmised that there would be less functional redundancy between the
enzymes, enabling us to distinguish the functional contributions of individual PATs. This
is evident from the requirement of Swf1 for cell viability, which is the first report of an
essential DHHC-PAT and supports the view that PATs occupy functional niches.
Furthermore, I showed biochemically a clear requirement for Erf2 in Ras1 and Rho3
palmitoylation in fission yeast, in contrast to reports in budding yeast12,
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63.

The

unambiguous PAT-substrate pairs in fission yeast facilitated this study and given the
apparent parallels of PAT-mediated protein palmitoylation between yeasts and metazoa,
studying this simple machinery will provide insights into equivalent controls in
mammals.
It remains to be determined how levels of a PAT affect its substrate specificity.
One possibility is a difference in catalytic efficiency (kcat/KM) and this is supported by the
discovery of specificity determinants on both the PATs and their substrates that dictate
enzyme-substrate interactions66,

67.

In addition, level-dependent changes in PAT

localization might alter substrate availability. For example, DHHC2 translocates to postsynaptic membranes upon neuronal stimulation, where it increases palmitoylation and
synaptic targeting of PSD9551. In this study, however, changes in PAT localization are
unlikely to account for the difference in Ras1 and Rho3 palmitoylation since both
substrates are localized to the same compartments in vegetative cells28, 144. Alternatively,
there may be depalmitoylating thioesterases or competing cellular factors that target
substrates differentially40, 84, 86, 87.
As global proteomic studies rapidly expand the known list of proteins that are
reversibly modified with this lipid moiety10-18, palmitoylation is proposed to be a major
cellular regulator. This is supported by expression profiling experiments in flies and
humans in which transcript levels of specific PATs vary widely across tissues70,

71.

Neuronal differentiation signals were found to induce the PAT degradation via the
ubiquitin-proteosome pathway74. In addition, PAT overexpression is associated with a
variety of human cancers and induces cellular transformation (summarized in Table 1.2).
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Along with these results, this study suggests critical roles for the control of PAT levels
and regulation of palmitoylomes in cellular development and disease. Although the
palmitoylation machinery is more elaborate in multicellular eukaryotes, the conservation
of PAT function and of specific PAT:substrate pairs between yeast and humans12, 58, 59
indicates that the conclusions of this study are relevant in predicting regulatory roles of
palmitoylation in major developmental transitions in metazoa.
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Materials and Methods
Genotype of haploid S. pombe strains used.
Strain
PN1
PN4
Mz53
Mz56
Mz166
Mz170
Mz126
Mz132
Mz120
Mz124
Mz184
Mz188
Mz254
Mz257

Genotype

Source

hh+
h- erf2Δ::NatMX6
h+ erf2Δ::NatMX6
h- erf4Δ::KanMX6
h+ erf4Δ::KanMX6
h- akr1Δ::KanMX6
h+ akr1Δ::KanMX6
h- pfa5Δ::KanMX6
h+ pfa5Δ::KanMX6
h- erf2Δ::NatMX6 erf4Δ::KanMX6
h+ erf2Δ::NatMX6 erf4Δ::KanMX6
h- akr1Δ::KanMX6 pfa5Δ::KanMX6
h+ akr1Δ::KanMX6 pfa5Δ::KanMX6
h+ erf2Δ::NatMX6 leu1-32::pDUAL(leu1 nmt41:HFY-erf2) ade-M216
ura4-D18
h+ erf2Δ::NatMX6 leu1-32::pDUAL(leu1 nmt41:HFY-erf2(DHHA))
ade-M216 ura4-D18

Nurse lab
Nurse lab
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

YN464
h- leu1 pREP1(nmt1:mei4)
(FY12642)*
Mz471
h- pat1-114 nmt1:erf2::KanMX6 rho3-HA3::KanMX6
Mz492
h- pat1-114 nmt1:erf4::KanMX6 rho3-HA3::KanMX6
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3Mz476
HA3::KanMX6
h- pat1-114 nmt41:erf2::KanMX6 nmt41:erf4::KanMX6 rho3Mz504
HA3::KanMX6
Mz556
h- pat1-114 leu1-32::pDUAL(leu1 nmt1:erf2(DHHC))
Mz560
h- pat1-114 leu1-32::pDUAL(leu1 nmt1:erf2(DHHA))
Mz518
h- nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3-HA3::KanMX6
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 mei4Δ::natMX6
Mz534
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3Δ::kanMX6
Mz488
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 ras1Δ::ura4+
Mz587
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 apm1Δ::ura4+
Mz629
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 exo70Δ::ura4+
Mz634
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 for3Δ::ura4+
Mz567
ura4-D18

Nakase et
al.197
This study
This study

Mz108
Mz199
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This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Genotype of diploid S. pombe strains used.
Strain
Mz5d
Mz9d
Mz21d
Mz25d
Mz29d
Mz17d
Mz60d
Mz74d
Mz64d
Mz88d
Mz68d
Mz89d
Mz129d
Mz189d
Mz197d

*Strain

Genotype
h-/h- pat-114/pat1-114 erf2-HA3::KanMX6/erf2-HA3::KanMX6
h-/h- pat-114/pat1-114 erf2Δ::NatMX6/erf2Δ::NatMX6
h-/h- pat-114/pat1-114 erf4Δ::KanMX6/erf4Δ::KanMX6
h-/h- pat-114/pat1-114 akr1Δ::KanMX6/akr1Δ::KanMX6
h-/h- pat-114/pat1-114 pfa5Δ::KanMX6/pfa5Δ::KanMX6
h-/h- pat-114/pat1-114 akr1Δ::KanMX6/akr1Δ::KanMX6
pfa5Δ::KanMX6/pfa5Δ::KanMX6
h-/h- pat-114/pat1-114 ras1Δ::KanMX6/ras1Δ::KanMX6
h-/h- pat-114/pat1-114 isp3Δ::KanMX6/isp3Δ::KanMX6
h-/h- pat-114/pat1-114 rho3Δ::KanMX6/rho3Δ::KanMX6
h-/h- pat-114/pat1-114 isp3-HA3::KanMX6/isp3-HA3::KanMX6
h-/h- pat-114/pat1-114 rho3-HA3::KanMX6/rho3-HA3::KanMX6
h-/h- pat-114/pat1-114 rho3-HA3::KanMX6/rho3-HA3::KanMX6
erf2Δ::NatMX6/erf2Δ::NatMX6
h-/h- pat1-114/pat1-114 nmt41:erf2::KanMX6/nmt41:erf2::KanMX6
rho3-HA3::KanMX6/rho3-HA3::KanMX6
h-/h- pat1-114/pat1-114 erf2+/erf2Δ::ura4+ rho3-HA3::KanMX6/rho3HA3::KanMX6 ura4-D18/ura4-D18
h-/h- pat1-114/pat1-114 nmt1:erf2::KanMX6/nmt1:erf2::KanMX6
nmt1:erf4::KanMX6/nmt1:erf4::KanMX6
rho3-HA3::KanMX6/ rho3-HA3::KanMX6

Source
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

was obtained from the Yeast Genetic Resource Center of Japan, supported by the

National Bioresource Project (YGRC/NBRP).
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Strain construction and growth conditions. Standard media and methods were used145,
146.

All experiments were carried out in minimal medium (EMM) and minimal medium

plus supplements (EMM4S) for prototrophic and auxotrophic strains respectively at 25
°C unless otherwise noted. When applicable, strains were generated by tetrad dissection
and validated by marker segregation or PCR. Deletion strains, strains expressing erf2HA3, isp3-HA3, and those expressing erf2 and erf4 from nmt promoters were constructed
by PCR integration147. For Rho3, the HA3-tag sequence was inserted in-frame 42 bp
upstream of its termination codon by PCR integration. Functional rescue in erf2Δ cells
was performed using the pDUAL plasmid (RIKEN BRC, Japan) expressing YFP-FLAGHis6-erf2 under the nmt41 promoter, which was linearized and integrated into the leu1
locus. The Quikchange XL II kit (Stratagene) was used for site-directed mutagenesis of
the erf2 DHHC motif. Homozygous diploids were obtained by incubating midlog cultures
of haploid cells with 20 µg/ml Carbendazim (Sigma) for 4.5 hours at 25 °C and screening
colonies on YES + phloxin B plates.

Synchronized Pat1-driven meiosis. Pat1-driven meiosis in diploid pat1-114/pat1-114
cells was carried out as described135. Midlog cultures grown in EMM, which contains
0.5% NH4Cl, were filter-washed three times with nitrogen-free minimal medium (EMMN) using the Microfil filtration system (Millipore), and resuspended in EMM-N for 14
hours at 25 °C. Meiosis was induced by shifting the cultures to 34 °C in the presence of
0.05% NH4Cl. t=0 is defined as the time of the temperature shift.
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erf2 and/or erf4 overexpression from thiamine-repressible nmt promoters. Cultures
were grown to midlog in EMM plus 10 mg/mL thiamine at 25 °C. erf2 and/or erf4
expression from nmt promoters was induced by filter-washing the cells three times with
EMM as described above. The cells were resuspended in EMM and growth was
maintained at 25 °C. The cultures were diluted with EMM approximately every 12 hours
for the duration of each experiment to keep OD595 <0.6 and in the presence of nutrients.
t=0 is defined as the time of thiamine removal.

Flow cytometry. DNA content was analyzed by flow cytometry using ethanol-fixed and
propidium iodide-stained cells (2 µg/mL propidium iodide in 50 mM sodium citrate) on a
BD FACS Calibur and analyzed using FlowJo software.

Cell size measurements and DNA staining. For cell size measurements, live cells were
stained with Blankophor (MP Biomedicals). For DNA staining, ethanol-fixed cells were
stained with DAPI. Images were acquired in Metamorph (MDS Analytical Technologies)
using an Axioplan 2 microscope (Carl Zeiss) and a CoolSNAP HQ camera (Roper
Scientific). Cell size measurements were obtained using the Pointpicker plug-in of Image
J (National Institute of Health).

Immunofluorescence microscopy. Cells were fixed at the indicated time points in 3.7%
formaldehyde for 30 minutes at 25 ºC, washed three times in PEM (100 mM Pipes, 1 mM
EGTA, 1 mM MgSO4 pH 6.9), and digested with 0.25 mg/mL zymolyase in PEMS (PEM
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+ 1.2 M Sorbitol) for 20 min at 37 ºC. Cells were then permeabilized by treatment with
PEMS + 1% Triton X-100 for 30 s, after which they were recovered in PEMBAL (PEM
with 1% BSA, 0.1% NaN3, 100 mM lysine hydrochloride) for incubation with α-HA
antibody (12CA5, mouse monoclonal) at 1:1000 dilution overnight at room temperature.
After three washes in PEMBAL, samples were incubated with Alexa 568-conjugated
anti-mouse secondary antibody (Invitrogen) at 1:2000 dilution for 3 hours in the dark at
room temperature. Cells were then washed with PEMBAL and PBS. For imaging, cells
were stained with 2 µg/mL DAPI to visualize nuclei. Microscopic images were acquired
in Metamorph (MDS Analytical Technologies) using a 63x objective on an Axioplan 2
(Carl Zeiss, Inc.) epifluorescence microscope and a CoolSNAP HQ camera (Roper
Scientific), with the same exposure settings for all images.

Quantitative RT-PCR. Total RNA was extracted using acidic phenol, DNase I-treated,
and purified with the RNeasy kit (Qiagen). RNA concentration was quantified and its
integrity was determined by agarose gel electrophoresis. cDNA was synthesized using
random hexamers and the SuperScriptIII First Strand Synthesis SuperMix (Invitrogen).
Relative quantification of cDNA was carried out in triplicate for each independent
experiment using qPCR MasterMix Plus for SYBR Green (Applied Biosystems) on an
ABI 7900 Real-Time PCR system. Primers used for quantitative PCR are listed in
Supplementary Table 2. Standard curves were generated using least six 2-fold serial
dilutions of a control sample and values within the linear exponential phase were used to
calculate relative concentrations after normalization to the endogenous actin controls.
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Oligonucleotide primers used in quantitative RT-PCR.
Gene

ID

Left

Right

actin

SPBC32H8.12c CGAACGTGAAATTGTTCGTG GGAGGAAGATTGAGCAGCAG

mde5

SPAC25H1.09 TTGCCGGACATTGATACAGA CCGTCGATTTTGAACTGCTT

erf2

SPBC3H7.09

CTTTTTGGCTCTGGCATCAT

AATTCCTGGATCAGCAGTCG

erf4

SPAC3F10.07c CGCAATATGGGGTTTTTGAG GGCAGAGGGAAGTGTTCGTA

pfa3

SPBC2F12.15c TGCCATCACCAAAACTTTCA TCATTCCAACAGCAAAAGCA

pfa5

SPBC691.01

swf1

SPBC13G1.07

akr1

SPAC2F7.10

GGTGATTTACCATGGGATCG GAAGCGGCAAAATCCAATTA
TCCATACTCCGCCTTGGTTA

CCCAGTTCCCCTTCACTTTT

TTAGCCGCTAGTCAGGGAGA AATGCAGTTGCTCCACCTTC

Metabolic labeling and preparation of cell lysates. Cells were labeled with 10 µ M of
alk-16 (20-50 mM DMSO stock) for 15 min, washed once with PBS prior to liquid
nitrogen freezing and storage at -80 °C. For inhibitor experiments, cells were
preincubated for 30 min with either 200 µ g/mL CHX or 200 µ M 2BP, which were
maintained in the cultures during alk-16 labeling. Competition experiments were carried
out with various palmitate concentrations in the cultures during metabolic labeling. To
prepare cell lysates, Brij lysis buffer (1% (v/v) Brij-97, 150 mM NaCl, 50 mM
triethanolamine pH 7.4, 5× concentration of Roche EDTA-free protease inhibitor
cocktail, 10 mM PMSF) and acid-washed glass beads (Sigma) were added to the frozen
yeast cell pellets, which were lysed (3 x 20 s) using the Fastprep homogenizer (Thermo
Scientific) at 4 min intervals to avoid overheating. Lysates were spun at 1,000 g for 5 min
to remove cellular debris. Typical lysate protein concentrations of 5-10 mg/mL were
obtained, as quantified using the BCA assay (Pierce).
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Immunoprecipitations and CuAAC. For analyses of whole cell lysates, 50 µg of protein
was diluted with Brij lysis buffer to a final volume of 44.5 µL, to which 5.5 µL of freshly
mixed CuAAC reagents were added. The CuAAC reagents consisted of 1 µL az-Rho (5
mM stock solution in DMSO), 1 µL tris(2-carboxyethyl)phosphine hydrochloride (TCEP)
(50 mM freshly prepared stock solution in deionized water), 2.5 µL tris[(1benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (2 mM stock solution in 1:4
DMSO:t-butanol) and 1 µL CuSO4·5H2O (50 mM freshly prepared stock solution in
deionized water). After 1 hour at room temperature, proteins were methanol-chloroform
precipitated to remove excess CuAAC reagents. The protein pellets were air-dried and
resuspended in SDS buffer (4% (w/v) SDS, 150 mM NaCl, 50 mM triethanolamine pH
7.4) by sonication before SDS-PAGE. For Ras1 and HA immunoprecipitations, 1-3 mg of
cell lysate was added to 4 µg anti-Ras antibody (Ras10, Millipore) with 25 µL Protein A
agarose (Roche) or to 15 µL of anti-HA antibody–conjugated agarose (3F10, Roche)
respectively. After 2 hours incubation with rocking at 4 °C, the beads were washed three
times with ice-cold RIPA buffer (1% (v/v) Triton X-100, 1% (w/v) sodium deoxycholate,
0.1% (w/v) SDS, 50 mM triethanolamine pH 7.4, 150 mM NaCl). The washed beads
were resuspended in 20 µL of PBS and 2.25 µL freshly-mixed CuAAC reagents described
above. The beads were then washed three times with ice-cold RIPA buffer prior to boiling
in SDS buffer for SDS-PAGE.
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In-gel fluorescence scanning and Western blots. Fluorescence gels were visualized on a
Typhoon 9400 variable mode imager (GE Healthcare) at excitation 532 nm/emission 580
nm. For Western blotting, proteins separated by SDS-PAGE were transferred to
nitrocellulose membranes and probed with the following antibodies: anti-Ras (Ras10,
Millipore), anti-tubulin (Tat1, gift from Keith Gull) and anti-HA (3F10, Roche). To avoid
visualizing the light chain band in anti-Ras1 immunoblots of Ras1 immunopurifications,
an Fc-specific anti-mouse-HRP secondary antibody (A2544, Sigma) was used. Blots
were developed using the enhanced chemiluminescence kit (GE Healthcare). Images
were processed using Image J.

Affinity enrichment and mass spectrometry. CuAAC reagents (az-azo-biotin) were
added to 10 mg cell lysate at the same concentrations described above. Proteins were
methanol-precipitated and resulting air-dried protein pellets were resuspended in 1 mL
SDS buffer containing 10 mM EDTA by sonication. The mixture was diluted 1:3 with
Brij lysis buffer and incubated with 100 µL of washed streptavidin agarose resin (Pierce)
for 1 hour on a nutating mixer at room temperature. The beads were then washed once
with 0.2% (w/v) SDS in PBS, three times with PBS and twice with 250 mM ammonium
bicarbonate (ABC). Beads were resuspended in 500 µL 8 M urea, and reactive cysteines
were alkylated by addition of 25 µL 200 mM TCEP and 25 µL 400 mM iodoacetamide
for 30 min. The beads were washed twice with 50 mM ABC. Two sequential elutions of
proteins from the resin were performed by incubating the beads with 250 µL of 25 mM
sodium dithionite in 50 mM ABC with 0.1% (w/v) SDS for 30 min each. Proteins were
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concentrated using YM-10 Centricons (Millipore), dried in a speed vac and separated by
SDS-PAGE. Upon staining with Coomassie blue, each lane was cut into 10 slices for
trypsin digestion and peptide extraction. Extracted peptides were dried and resuspended
in 0.1% (v/v) trifluoroacetic acid for mass spectrometry identification. Acquired MS/MS
spectra were analyzed using the Sequest search engine to identify proteins from the
primary sequence database obtained from the S. pombe GeneDB. Exported Sequest
results were analyzed using Scaffold (Proteome Software).
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CHAPTER 4
A FISSION YEAST MODEL FOR PALMITOYLATION-MEDIATED
REGULATION OF SIGNAL TRANSDUCTION

Introduction
In S. pombe, meiosis is part of a highly coordinated sexual differentiation process that is
triggered by nutrient depletion. This important switch from the mitotic cell cycle to
meiosis involves striking changes global gene expression135, 136 and is governed by master
regulator Mei2, an RNA binding protein (Fig. 4.1a). Mei2 binds to meiRNA, forming a
dot structure that sequesters Mmi1 and enables stable expression of meiosis-specific
transcripts critical for meiosis I148. Although the molecular functions of Mei2 in initiating
and orchestrating the meiotic program are not fully elucidated, it is apparent that Mei2 is
the master regulator that integrates extracellular cues (stress, nutrients and pheromones),
primarily through transcription factor Ste11, and drives the meiosis (Fig. 4.1b). Mei2
function is tightly regulated by the Pat1 kinase, which phosphorylates and inactivates
Mei2, preventing meiotic entry during the mitotic cell cycle149. Together, the Pat1-Mei2
system constitute the core mitosis-meiosis switch in fission yeast. Thermal inactivation of
Pat1 in cells carrying the temperature sensitive pat1-114 allele or even weak expression
of a constitutively active Mei2 (Mei2SATA) is sufficient to induce ectopic meiosis and
sporulation regardless of nutritional cues and ploidy of the cells137-139,

149.

Under

physiological conditions, however, complete inactivation of Pat1 and meiotic induction
strictly requires the stoichiometric inhibitor Mei3, which is only expressed in
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heterozygous diploids formed after successful conjugation150-152. Working in concert,
these key cellular factors integrate environmental cues and control cellular commitment
to meiosis.

Figure 4.1 | Key cellular factors underlying the mitotic-meiotic decision in S. pombe. a,
RNA-binding protein Mei2 is a critical regulator of meiotic initiation and progression. A number
of meiosis-specific transcripts carry DSR (determinant of selective removal) regions, which
renders them eliminated during the mitotic cell cycle by Mmi1. During meiotic prophase, Mei2,
together with meiRNA, sequesters Mmi1, so that meiosis-specific transcripts become free from
Mmi1-dependent elimination and be expressed. Adapted from Harigaya et al.148 b, Key regulators
integrate different signal transduction pathways (boxes) to regulate the initiation of meiosis.
Green: positive regulators. Red: negative regulators.

In the previous chapter, I demonstrated that rheostatic control of Rho3
palmitoylation by varying levels of the Erf2-Erf4 PAT is a major determinant of meiotic
commitment in S. pombe. In this chapter, I seek to determine where Erf2-Erf4 fit in the
regulatory network of the meiotic program. Epistasis analysis revealed genetic
interactions between erf2, erf4 and the key regulators of meiotic commitment (Fig. 4.1b)
as well as the components of the stress-activated protein kinase (SAPK) pathway.
Consistent with this, various stress response defects were observed for erf2∆ and erf4∆
cells, which were associated with changes in global palmitoylation profiles. Taken
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together, these results, though somewhat preliminary, suggest an intriguing role of the
Erf2-Erf4 PAT in coordinating cellular response to stress and sexual differentiation.
Given the homology between components of the S. pombe and mammalian MAPK/
SAPK pathways, if validated, this system offers a powerful tool to study palmitoylationmediated regulation of signal transduction for diverse stimuli.
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Results
pat1-114 provides a sensitized genetic background for Erf2-induced meiosis
In normal meiosis, heterozygous diploid zygotes formed after successful conjugation
express Mei3, which inactivates Pat1 and leads to activation of Ste11 and Mei2, which in
turn drives meiotic entry (Fig. 4.2a, box). As described in Chapter 3, overproduction of
the Erf2-Erf4 PAT is sufficient to trigger a meiotic phenotype in otherwise proliferating
cells. I further determined that induction of this meiotic phenotype requires canonical
meiotic regulators, specifically Ste11 and Mei2, but not Mei3 (Fig. 4.2a). The latter is not
unexpected since mei3 expression is restricted to heterozygous zygotes whereas Erf2Erf4 overproduction is sufficient to induce meiosis in haploid and homozygous diploid
cells. This also indicates that the Erf2-induced meiotic phenotype is not a result of
unscheduled mei3 expression. Curiously, a routine control experiment revealed that the
meiotic phenotype observed with Erf2-Erf4 overproduction is only apparent in the
pat1-114 but not pat1+ genetic background (Fig. 4.2b). Since lower Pat1 kinase activity
has been reported for pat1-114 cells even at permissive temperature153, I hypothesized
that high Erf2-Erf4 activity induces the meiotic phenotype in these sensitized cells by
activating the Ste11-Mei2 pathway or inactivating Pat1 via a Mei3-independent
mechanism.
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Figure 4.2 | Erf2-Erf4 function in meiotic control is revealed in pat1-114 cells. DAPI (left)
and DIC (right) images of haploid cells 96 h after erf2 and erf4 co-overexpression. Cells were
maintained in the presence of nutrients at permissive temperature. Scale bars, 10 µm. a, Epistasis
analysis revealed that canonical meiotic regulators Ste11 and Mei2, but not Mei3, are required for
Erf2-Erf4 induced meiosis in pat1-114 cells. Cellular factors involved in the S. pombe mitosismeiotic switch are indicated in the box. In normal meiosis, Mei3 inactivation of Pat1 leads to
activation of Ste11 and Mei2, which drives meiotic entry. Activation and inhibition are
represented by arrows and crossing bars, respectively. b, Erf2-Erf4 induced meiosis is observed in
pat1-114 but not pat1+ cells.

Erf2-induced meiosis requires the stress-activated protein kinase (SAPK) pathway
To test this, I determined the epistatic relationship of Erf2-Erf4 overproduction to a
number of mutants constructed in the pat1-114 genetic background, focusing on the genes
in major pathways involved in the commitment to sexual differentiation in fission yeast.
These include the cAMP, the pheromone signaling MAPK and the SAPK pathways (Fig.
4.3b). Erf2-Erf4 was overproduced in haploid strains with deletions of different
components in each signaling pathway. Cells lacking components of the nutrient-sensing
cAMP pathway (rst2) or pheromone signaling pathway (ras1 and spk1) exhibited the
meiotic phenotype upon Erf2-Erf4 overproduction (Fig. 4.3a). In contrast, deletion of
kinases in the SAPK pathway, wis1 and sty1, suppressed the meiotic phenotype (Fig.
4.3a). Deletion of a specific Sty1 effector, atf1, but not other Sty1 substrates (srk1 and
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smk2), also suppressed the meiotic phenotype (Fig. 4.3a). Given that Atf1 is required for
ste11 expression, these observations suggest that Erf2-Erf4 induces the meiotic phenotype
by activating Ste11-Mei2 via the Wis1-Sty1-Atf1 SAPK pathway (Fig. 4.3b). Such
activation is perhaps sufficient to overcome the Pat1-mediated meiotic repression in
pat1-114 cells, in which the Pat1 kinase is not fully active even at permissive
temperature.
Genetic interactions between erf2, erf4 and core components of the SAPK
pathway raises the possibility that Erf2-Erf4, in addition to their roles in meiotic
commitment, may also be important in controlling cellular response to environmental
stresses (Fig. 4.3b). Interestingly, both Sty1 and Atf1 are involved in both sexual
differentiation as well as stress response in fission yeast, suggesting coordination between
both processes154. Is Erf2-Erf4 also involved in general stress response? In the rest of this
chapter, I present a series of preliminary observations to support the role of the Erf2-Erf4
PAT in the stress response pathway.
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Figure 4.3 | Epistasis analysis reveals that Erf2-induced meiosis requires the SAPK
pathway. a, DAPI (left) and DIC (right) images of haploid cells 96 h after erf2 and erf4 cooverexpression. Cells were maintained in the presence of nutrients at permissive temperature.
Scale bars, 10 µm. b, Signaling pathways involved in the commitment to sexual differentiation in
fission yeast. Red, gene products are required for Erf2-induced meiosis. Blue, gene products are
not required for Erf2-induced meiosis. Activation and inhibition are represented by arrows and
crossing bars, respectively.
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erf2∆ cells are inviable at high temperatures
First, erf2∆ and erf4∆ cells are inviable at 36 °C (Fig. 4.4). Notably, no significant growth
defects was observed at 34 °C, the restrictive temperature for inactivating Pat1 in the
synchronous meiosis experiments described in the Chapter 3, suggesting that this growth
defect at high temperatures does not contribute to the meiotic delay of erf2∆ cells. In
contrast, deletion of the other PATs does not affect growth at higher temperatures,
indicating a specific role of the Erf2-Erf4 PAT in maintaining cell viability at elevated
temperatures.

Figure 4.4 | erf2∆ and erf4∆ cells are temperature
sensitive. Serial 10-fold dilutions of exponentially
growing cultures of the indicated strains, normalized
to the same OD, were spotted on YE4S plates and
incubated for 4 days at the indicated temperatures.
The pat1-114 strain was used as a positive control
for temperature sensitivity. The deletions were made
in a pat1+ wild type background.
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erf2∆ cells are delayed in G1 arrest during nitrogen starvation
Second, erf2∆ cells are delayed in their nitrogen starvation response. When homothallic
fission yeast cells are subjected to depravation of a nitrogen source, they arrest at G1 of
the cell cycle prior to mating and sporulation. Mutants deficient in sty1 or atf1 deficient
in G1 arrest and sterile154, 155. Compared to wild type cells, erf2∆ cells arrest much less
efficiently at G1 and arrest in these cells takes a longer time, as observed by the relative
sizes of the 1C peak 8 h after nitrogen depletion (Fig. 4.5a). This inefficient G1 arrest in
erf2∆ cells is accompanied by the appearance of misshapened cells with abnormally thick
septa (Fig. 4.5a).
To determine whether Erf2 PAT activity has an impact on the global protein
palmitoylation during nitrogen starvation, I profiled palmitoylated proteins by in-gel
fluorescence at different times after transfer to a nitrogen-free medium. In wild type cells,
palmitoylation of at least two distinct substrates between 25-37 kDa was maintained for
7-8 h after nitrogen removal despite large-scale protein degradation as observed by
Coomassie staining of the gel (Fig. 4.5b). On the other hand, in erf2∆ cells,
palmitoylation of these substrates were only sustained for 3-4 h after nitrogen removal
(Fig. 4.5b). It would be interesting to determine what these Erf2 substrates are and how
they contribute to G1 arrest in response to nitrogen depletion.
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Figure 4.5 | erf2∆ cells are defective in G1 arrest in response to nitrogen starvation. a,
Exponentially growing cells were filter-washed and transferred to nitrogen-free medium for the
indicated times. Right panel: DNA content analysis of indicated cells pre- and 8 h post- nitrogen
removal. Left panels: DIC images of the indicated cells 8 h after nitrogen removal. Scale bars, 10
µm. b, Alk-16 fluorescence profiles of palmitoylated substrates of indicated strains at different
times after nitrogen removal (top panels) and Coomassie staining of the gels (bottom panels). (-):
DMSO controls.
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To investigate whether erf2∆ cells can sense nutritional cues, I performed the following
nutritional shift experiment. It was previously reported that cells shifted from a good
nitrogen source (glutamate) to a poor nitrogen source (proline) are advanced into mitosis,
which is observed as a transient increase in the proportion of dividing cells and a reduced
cell length at division156. It is evident that erf2∆ cells, like wild type cells, are able to
sense and respond to the nutritional glutamate-proline downshift by advancing mitotic
onset, which leads to a peak in the percentage of dividing cells about 1 h after nutritional
shift and a reduced cell size at division (Fig. 4.6). These results demonstrate that the
delay in G1 arrest upon nitrogen starvation in erf2∆ cells was not due to their inability to
sense nutritional cues.

Figure 4.6 | erf2∆ cells respond to nutrient shifts. Exponentially growing cultures in glutamatecontaining medium were shifted to proline-containing medium at t=0 h. At the indicated times
after the shift, cells were stained with blankophor. The percentage of septated cells (left panel,
n≥200) and cell length at division (right panel, n=20) were determined by counting and
measuring blankophor-stained cells. Previously reported values for wild type cells and a TOR
mutant that is unable to respond to nutritional shift are also included156. Although the trend holds,
discrepancies between the two studies may be due to different growth temperatures (25 °C vs 32
°C) and the use of synchronous vs asynchronous cultures.
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erf2∆ cells exhibit morphological defects during recovery from stationary phase
Third, erf2∆ and erf4∆ cells exhibit are defective in growth recovery from stationary
phase. Upon growth to saturation, fission yeast cells exit the mitotic cycle and enter
stationary phase, accumulating in G1 or G2 depending on whether they are deprived of
nitrogen or carbon, respectively157. Because of the growth medium used, when haploid
cells are grown to high densities, glucose is usually limiting and cells accumulate in
G2157. When the starved cultures were reinoculated into fresh medium, wild type cells
exit stationary phase and resume normal cell division (Fig. 4.7a). In contrast,
morphological defects were observed in erf2∆ and erf4∆ cells after dilution into fresh
medium. These include the appearance of misshapened and multiseptated cells as well as
excessive deposition of cell wall material and abnormally thick septa (Fig. 4.7a). The
heterogeneity of these cells can be observed by the spread of data points on the forward/
side scatter plots compared to wild type (Fig. 4.7d). The failure by the multiseptated cells
to complete cytokinesis is also reflected in the DNA content analysis, where a 4C peak is
observed for erf2∆ cells (Fig. 4.7c). Interestingly, this phenotype is transient and resolves
over time as the cells resume normal growth but can be observed if the culture is again
starved and refed (Fig. 4.7b), suggesting that these defects in erf2∆ and erf4∆ cells are
restricted to the initial recovery period from stationary phase.

109

Figure 4.7 | erf2∆ cells exhibit morphological defects during recovery from starvation at
high cell density. Cultures at OD595 ~3 were incubated at 32 °C for 16 h prior to dilution into
fresh medium. Indicated times refer to the time after starved cultures were diluted into fresh
medium. a, DIC images of indicated strains 5.5 h after dilution of starved cultures into fresh
medium. Scale bars, 10 µm. b, Percentage of cells with defective morphology (misshapened,
multiseptated, excessive cell wall material) for indicated strains (n=200). #: cultures were grown
to high density and then rediluted into fresh medium. c, DNA content analysis of indicated
strains. d, Forward (FSC) and side (SSC) scatter plots of the indicated strains.
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To determine whether Erf2 PAT activity has an impact on the global protein
palmitoylation during recovery from stationary phase, I profiled palmitoylated proteins
by in-gel fluorescence at different time points after dilution of the starved cultures into
fresh medium. In wild type cells, there is a striking and reproducible increase in protein
palmitoylation 1 h after refeeding the cultures (Fig. 4.8a). Interestingly, this increase in
global protein palmitoylation, which is absent in erf2∆ cells (Fig. 4.8a), occurs before the
appearance of the multiseptated erf2∆ cells as observed by the appearance of the 4C peak
by flow cytometry analysis (Fig. 4.8b). It would be interesting to determine how these
modified substrates contribute to recovery from stationary phase and if they are the same
substrates that mediates the nitrogen starvation response.

Figure 4.8 | Different palmitoylation profile of erf2∆ cells during recovery from starvation at
high cell density. Cultures at OD595 ~3 were incubated at 32 °C for 16 h prior to dilution into
fresh medium. Indicated times refer to the time after starved cultures were diluted into fresh
medium. a, Alk-16 fluorescence profiles of palmitoylated substrates of indicated strains (top
panels) and Coomassie staining of the gels (bottom panels). (-): DMSO controls. b, DNA content
analysis of the indicated strains.
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Summary and Discussion
In this chapter, I showed genetic interactions between erf2, erf4 and important regulators
of meiotic commitment as well as the components of the SAPK pathway. Together with
the abnormal stress responses observed in erf2∆ and erf4∆ cells, these preliminary results
suggest potential role(s) of the Erf2-Erf4 PAT in coordinating cellular response to stress
and sexual differentiation.
In S. pombe, the SAPK pathway mediates a variety of cellular responses to heat,
oxidative, nutritional, osmotic and UV stresses, controlling the initiation of sexual
differentiation/mating and stationary phase survival as well as resistance to drugs and
heavy metals. Sty1 is the core MAPK module in the SAPK pathway. Sty1 is activated by
the Wis1 MAPKK158, 159, which in turn is activated by MAPKKK’s Wis4 and Win1160-164
(Fig. 4.9a). Atf1 is a target transcription factor downstream of Sty1 and directs stressspecific gene expression155, 165. Consistent with Sty1 and its targets playing critical roles
in general stress response, inactivation of sty1 or atf1 results in cells that are
hypersensitive and fail to respond appropriately to a variety of stresses, including the
inability to grow at high temperatures, survive stationary phase growth and arrest cell
cycle in G1 upon nitrogen depletion154, 155. Similar phenotypes observed in erf2∆ cells
suggest role(s) for Erf2 and protein palmitoylation in regulating the general stress
response. This is further suggested by the altered global palmitoylation profiles in erf2∆
cells under these conditions. It would be interesting to identify the Erf2 substrates
involved in these stress responses and determine how palmitoylation regulates their
function. Nonetheless, more work will have to be done to validate the function of the
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Erf2-Erf4 PAT in the general stress response and if it has a direct or indirect regulatory
role on the SAPK pathway and meiotic commitment (Fig 4.9a).

Figure 4.9 | A fission yeast model for palmitoylation-mediated regulation of signal
transduction. a, A model for the role(s) of the Erf2-Erf4 PAT in coordinating cellular response to
stress and sexual differentiation. Pathways indicated by dashed lines are conceptual and
speculative. Activation and inhibition are represented by arrows and crossing bars, respectively.
b, Homology between mammalian and S. pombe SAPK pathways.
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Given the homology between components of the S. pombe and mammalian SAPK
pathways, if validated, the system described above offers a powerful tool to study
palmitoylation-mediated regulation of signal transduction. Besides structural homology
between the SAPKs and transcription factors, the SAPK cascades in fission yeast and
mammals are similarly regulated and control the activity of transcriptional factors that
determine biological responses to various stresses (Fig. 4.9b). In mammals, the SAPK
pathways are activated by environmental stimuli similar to S. pombe and are involved in
apoptosis, DNA repair, cellular proliferation and differentiation166. Stress signals are
delivered to the SAPKs by small GTPases of the Ras and Rho (Rac, Rho, Cdc42)
families, some of which are known to be reversibly palmitoylated11, 167. Ras, for example,
is proposed to signal through distinct MAPK/SAPK pathways from different membrane
compartments19, 26, 168, which is in turn regulated by palmitoylation22, 24. Nonetheless,
evidence for differential signal outputs from each compartment is limited and largely
confined to overexpression studies of molecules re-targeted to ectopic compartments.
Therefore, this fission yeast system, in which a specific PAT function is coupled to a
conserved signaling pathway, provides a tractable model to uncover the role of protein
palmitoylation in generating spatial complexity of signaling networks in a physiological
context.
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Materials and Methods
Genotype of S. pombe strains used.
Strain

PN1
PN2283
Mz53
Mz166
Mz126
Mz120
Mz254
Mz364
Mz476
Mz518
Mz531
Mz626
Mz630
Mz632
Mz564
Mz551
Mz571
Mz624
Mz644
Mz572
Mz627
Mz628

Genotype

hh- pat1-114
h- erf2Δ::NatMX6
h- erf4Δ::KanMX6
h- akr1Δ::KanMX6
h- pfa5Δ::KanMX6
h- akr1Δ::KanMX6 pfa5Δ::KanMX6
h- pfa3Δ::KanMX6 ade6-M216
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3HA3::KanMX6
h- nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3HA3::KanMX6
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6
mei2Δ::natMX6 ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6
mei3Δ::ura4+ ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6
ste11Δ::ura4+ ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 atf1Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 spk1Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 sty1Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 wis1Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 wis4Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 win1Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rst2Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 srk1Δ::ura4+
ura4-D18
h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 cmk2Δ::ura4+
ura4-D18
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Source

Nurse lab
Nurse lab
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Strain construction and growth conditions. Standard media and methods were used145,
146.

Strains used in this study are listed in Supplementary Table 1. All experiments were

carried out in minimal medium (EMM) and minimal medium plus supplements
(EMM4S) for prototrophic and auxotrophic strains respectively at 32 °C unless otherwise
noted. When applicable, strains were generated by tetrad dissection and validated by
marker segregation or PCR. Deletion strains and those expressing erf2 and erf4 from nmt
promoters were constructed by PCR integration147.

Epistasis analysis. Cultures were grown to midlog in EMM plus 10 mg/mL thiamine at
25 °C. erf2 and/or erf4 expression from nmt promoters was induced by filter-washing the
cells three times with EMM as described above. The cells were resuspended in EMM and
growth was maintained at 25 °C since these strains are constructed in a pat1-114
background. The cultures were diluted with EMM approximately every 12 hours for the
duration of each experiment to keep OD595 <0.6 and in the presence of nutrients. t=0 is
defined as the time of thiamine removal. At t=96 h, cells were harvested and ethanolfixed prior to DAPI staining and imaging.

Nitrogen starvation. Cultures were grown to midlog in EMM at 32 °C. Nitrogen was
removed by filter-washing the cells three times with nitrogen-free EMM (EMM-N) and
resuspending the cells in EMM-N. Cultures were then returned to 32 °C.
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Glutamate to proline nutritional shift. These experiments were conducted as reported156
with the exception that the cells were grown at 32 °C rather than 25 °C. Cultures were
grown to midlog in EMM plus 1 mg/mL glutamate at 32 °C. Nutritional shift to a poorer
nitrogen source was performed by filter-washing the cells three times with EMM plus
1.15 mg/mL proline. The cells were resuspened in EMM+proline and returned to growth
at 32 °C.

Recovery from high cell density starvation. Starter cultures at OD595 ~3 in EMM were
incubated for 16 h at 32 °C prior to dilution into fresh EMM at t=0. Indicated times refer
to the time after starved cultures were diluted into fresh medium. Most analyses were
performed at 5.5 h after dilution into fresh medium, when morphological defects were
observed for a large proportion of erf2Δ cells.

Flow cytometry. DNA content was analyzed by flow cytometry using ethanol-fixed and
propidium iodide-stained cells (2 µg/mL propidium iodide in 50 mM sodium citrate) on a
BD FACS Calibur and analyzed using CellQuest software (BD).
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Cell size measurements and cellular staining. For cell size measurements, live cells
were stained with Blankophor (MP Biomedicals). For DNA staining, ethanol-fixed cells
were stained with DAPI. Images were acquired in Metamorph (MDS Analytical
Technologies) using an Axioplan 2 microscope (Carl Zeiss) and a CoolSNAP HQ camera
(Roper Scientific). Cell size measurements were obtained using the Pointpicker plug-in of
Image J (National Institute of Health).

Metabolic labeling and preparation of cell lysates. Cells were labeled with 10 µ M of
alk-16 (20-50 mM DMSO stock) for 15 min, washed once with PBS prior to liquid
nitrogen freezing and storage at -80 °C. To prepare cell lysates, Brij lysis buffer (1% (v/v)
Brij-97, 150 mM NaCl, 50 mM triethanolamine pH 7.4, 5× concentration of Roche
EDTA-free protease inhibitor cocktail, 10 mM PMSF) and acid-washed glass beads
(Sigma) were added to the frozen yeast cell pellets, which were lysed (3 x 20 s) using the
Fastprep homogenizer (Thermo Scientific) at 4 min intervals to avoid overheating.
Lysates were spun at 1,000 g for 5 min to remove cellular debris. Typical lysate protein
concentrations of 5-10 mg/mL were obtained, as quantified using the BCA assay (Pierce).
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CuAAC. For analyses of whole cell lysates, 50 µg of protein was diluted with Brij lysis
buffer to a final volume of 44.5 µL, to which 5.5 µL of freshly mixed CuAAC reagents
were added. The CuAAC reagents consisted of 1 µL az-Rho (5 mM stock solution in
DMSO), 1 µL tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (50 mM freshly
prepared stock solution in deionized water), 2.5 µL tris[(1-benzyl-1H-1,2,3-triazol-4yl)methyl]amine (TBTA) (2 mM stock solution in 1:4 DMSO:t-butanol) and 1 µL
CuSO4·5H2O (50 mM freshly prepared stock solution in deionized water). After 1 hour at
room temperature, proteins were methanol-chloroform precipitated to remove excess
CuAAC reagents. The protein pellets were air-dried and resuspended in SDS buffer (4%
(w/v) SDS, 150 mM NaCl, 50 mM triethanolamine pH 7.4) by sonication before SDSPAGE.

In-gel fluorescence scanning. Fluorescence gels were visualized on a Typhoon 9400
variable mode imager (GE Healthcare) at excitation 532 nm/emission 580 nm. After
fluorescence scanning, gels were stained with Coomassie Blue for determination of
protein load. Images were processed using Image J.
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CHAPTER 5

GENERAL DISCUSSION

This thesis describes the development and application of chemical approaches to study
the function and regulation of protein S-palmitoylation, a uniquely reversible lipid
modification that primarily serves as an important membrane targeting mechanisms in
eukaryotes. Using fatty acid chemical reporters, combined with bioorthogonal labeling
conditions involving CuI-catalyzed azide-alkyne cycloaddition, I was able to specifically
and robustly detect lipid modified proteins by fluorescence. I further extended this
method to allow fluorescent detection of two distinct protein modifications on proteins of
interest and showed that this tandem imaging method can be used to efficiently monitor
dynamic palmitoylation in cells. These protocols are currently used by most members of
the lab on a routine basis as well as by multiple labs that we have collaborated with for
studying various protein modifications. Combining chemical and genetic approaches in
fission yeast, I showed that quantitative control of an acyltransferase complex during
meiosis results in differential activity on cognate substrates and shaping of the
palmitoylome, which is an important determinant for commitment to this major
transitional event in S. pombe. Based on this study, I propose that rheostatic control of
acyltransferase activity provides an important mechanism for regulating global protein
palmitoylation and that this may have significant impacts on major developmental
transitions.
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Fission yeast is a relevant and complementary model for palmitoylation studies
The genetically amendable fission yeast S. pombe, combined with the use of chemical
strategies that we have developed, is a relevant and complementary model for
understanding basic control mechanisms and function of protein palmitoylation. Its
simple PAT network facilitates dissection of the regulation and functional contribution of
individual PATs. Interestingly, Swf1 is required for cell viability134, and if validated to be
a bona fide PAT, would be the first report of an essential DHHC-PAT. Initial efforts to
make a conditional mutant by replacing the endogenous swf1 promoter with thiaminerepressible nmt promoters failed, suggesting that regulated swf1 expression is perhaps key
to its function in maintaining cellular viability. Why is swf1 essential? In budding yeast,
SWF1 palmitoylates SNAREs required for membrane fusion12, 45 and by homology, the
putative SNARE substrates of Swf1 in fission yeast, Psy1 and Syb1 , are essential for cell
viability134, 169, 170. Hence, it is likely Swf1 mediates essential cellular processes such as
membrane trafficking and fusion. It will be interesting to study the function of Swf1 by
means of temperature-sensitive or conditional switch-off alleles.
Although this thesis focuses on the palmitoylating machinery, some of the
preliminary experiments that I have conducted indicates that S. pombe would also be a
good system to study the depalmitoylation machinery. The fact that palmitate turns over
faster on Ras1 than the protein argues for the existence of protein thioesterase(s).
Disruption of the only Apt1 thioesterase homolog in fission yeast did not affect cell
viability, cell growth at high temperature and stationary phase, mating efficiency, steady
state Ras1 palmitoylation or global protein palmitoylation by in-gel fluorescence. It
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remains to be determined if the palmitate half-lives of Ras1 and other palmitoylated
substrates are different in wild type and apt1∆ cells. As discussed in Chapter 1, it is still
unclear if APT1 and related isoforms are the main depalmitoylating enzymes or if there
are potentially more enzymes to be uncovered. By homology to APT1 and inhibitor
studies14, 52, 84, it is likely that depalmitoylating enzymes are serine thioesterases. Given
that there are hundreds of serine/cysteine hydrolases encoded in the mammalian genome,
it is more practical to systematically screen candidate enzymes for the ability to
depalmitoylate proteins in fission yeast.

PAT levels matter: shaping palmitoylomes by rheostatic control of PAT activity
Evidence for regulation of palmitoylating and depalmitoylating enzymes are limited and
although individual PATs and APT1 have multiple substrates12, 65, 77, 82, studies tend to
focus on a single enzyme:substrate pair. For example, It would be interesting to
determine if the activity-sensitive translocation of DHHC2 affects palmitoylation of other
neuronal substrates besides PSD95 and if that contributes to modulation of synaptic
activity51. Our study in fission yeast, where we identified and monitored three cognate
Erf2-Erf4 substrates in vegetative and meiotic cells, offers a different perspective. We
showed that physiological control of Erf2-Erf4 activity levels underlie the differential
modification of its cognate substrates in distinct cellular states, suggesting that rheostatic
control of single or multiple PAT activities is a basic mechanism by which cells shape
their palmitoylomes. It raises the possibility that a single PAT can have different functions
and regulate different cellular processes depending on its levels. We further showed that
PAT level-dependent changes in palmitoylomes are important for cellular events such as
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meiotic commitment in fission yeast. This highlights the importance of studying PATs
and palmitoylomes in physiologically relevant contexts and provides a possible
explanation for the extensive biochemical and functional overlap between the PATs in
cellular studies involving non-physiological enzyme and substrate concentrations68, 69.
Because of technical difficulties, it remains to be determined how levels of a PAT
affect its substrate specificity. As previously discussed, one possibility is a difference in
“specificity constant” (kcat/KM) and this is supported by the discovery of specificity
determinants on both the PATs and their substrates that dictate enzyme-substrate
interactions66, 67. If this were the case, one would predict higher kcat/KM for substrates that
require lower PAT levels for effective palmitoylation and vice versa. I am currently
investigating the possibility of recognition domains on the substrates by first swapping
Rho3 and Ras1 palmitoylation motifs and asking if this affects the PAT level-dependence
of each substrate. Another possibility is that depalmitoylating thioesterases or competing
cellular factors target certain substrates more efficiently40, 84, 86, 87. This can be addressed
by comparing the palmitate turnover on the different Erf2 substrates. Alternatively, leveldependent changes in PAT localization might alter substrate availability. For example,
DHHC2 translocates to post-synaptic membranes upon neuronal stimulation and
mediates increased palmitoylation and synaptic targeting of PSD9551, implicating PAT
compartmentalization as a means to control activity-induced palmitoylomes. In our study,
however, subcellular localization is unlikely to account for the difference in Ras1 and
Rho3 palmitoylation since both proteins are localized to the same compartments in
vegetative cells28,

144.

These proposed mechanisms are not mutually exclusive since
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mobilization of PATs might be interpreted as an increase in local PAT concentration,
which might then increase protein palmitoylation by mass action or by titration of
competing cellular factors.

Conservation of specific PAT:substrate pairs
I showed that the Erf2 PAT in fission yeast, can have different substrate preferences and
that specific PAT-substrate pairs are needed for efficient palmitate transfer, which is
consistent with studies in mammals and budding yeast12, 65. Notably, the Erf2-Erf4:Ras1
PAT:substrate pairing in fission yeast is reminiscent of the ERF2-ERF4:RAS1/RAS2 and
DHHC9-GCP16:H-/N-Ras pairs in budding yeast and human, respectively58, 59. Given
that humans and yeast diverged about 1 billion years ago while S. pombe and S. cerevisae
diverged 300-400 million years ago, this suggests an evolutionary selection for specific
cognate PAT:substrate pairs, which would be unlikely if PATs have extensive overlapping
substrate preferences and were able to freely substitute for each other. Interestingly, the
Erf2-Erf4:Rho3 pair in fission yeast is also found in budding yeast12, raising the
possibility that DHHC9-GCP16 might also modify Rho GTPases in mammals. This is
further suggested by the large number of mammalian Rho GTPases with cysteines close
to the N- or C- terminus, which serve as potential palmitoylation sites (Fig. 5.1). If
DHHC9-GCP16 indeed does palmitoylate Rho proteins, it would be interesting to
determine if, like Erf2-Erf4, it can differentially modify Ras and Rho proteins.
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Figure 5.1 | Mammalian Rho GTPases. An unrooted phylogentic tree that is based on the
ClustlW alignment of the amino-acid sequences of the 20 Rho GTPase proteins. The tree
demonstrates the relationship between the different family members. EMBOSS pairwise
alignment was used to calculate the percentage of amino-acid-sequence identity within
subfamilies. High sequence similarity is found between proteins within the Rac and Rho
subfamilies, whereas the other subfamilies are much less similar. Adapted from Heasman et al.171
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Role of protein palmitoylation in other developmental transitions
The highly conserved Ras and Rho GTPases are essential for cellular differentiation and
development in mammals171. Conservation of PAT function and specific PAT:substrate
pairs between yeasts and humans suggests regulatory roles of palmitoylation in major
developmental transitions in metazoa. This is supported by expression profiling
experiments in flies and humans in which transcript levels of specific PATs vary widely
across tissues70,

71.

Neuronal differentiation signals were found to induce the PAT

degradation via the ubiquitin-proteosome pathway74. In addition, PAT mutation and
misregulation is associated with a variety of developmental defects as well as cancers in
humans (summarized in Table 1.2). It will be interesting to determine if the control of
PAT levels and regulation of palmitoylomes are important for cellular development and
disease.

Rho3 coordinates regulation of membrane trafficking and polarized exocytosis
We demonstrated that both the actin nucleating formin For3 and exocyst subunit Exo70,
but not the clathrin-adaptor Apm1, is required for the essential role of Rho3 in Erf2induced meiosis. A recent study proposed that polarized exocytosis in fission yeast, rather
than being a linear event of actin-dependent long-range vesicle transport followed by
exocyst-dependent vesicle tethering at the PM172, can be independently mediated by
either pathway173. Physical and/or genetic interactions between Rho3 and For3 as well as
different subunits of the exocyst complex indicates that Rho3 regulates and potentially
coordinates these actin-dependent and exocyst-dependent secretory pathways143, 144 (Fig.

126

5.2a). Interestingly, Rho3 is localized to the cell periphery as well as endomembranes
(Golgi/endosome), raising the possibility that Rho3 signaling, like Ras1, may be
compartmentalized. This is supported by studies showing that Rho3 colocalizes with For3
at the cell periphery143, 144 and with Apm1 at endomembranes174. Physical interactions
between Rho3 and For3 as well as Apm1 were validated biochemically144, 174. Spatial
compartmentalization may explain how Rho3 can control multiple pathways including
golgi/endosome trafficking, cytoskeletal organization and polarized exocytosis143, 144, 174
(Fig. 5.2b). This can be tested by artificially targeting Rho3 to different compartments
and measuring signaling outputs from each pathway biochemically and phenotypically.
How does Rho3 palmitoylation regulate meiotic commitment? If the
compartmentalized signaling model is correct, one would expect factors that regulate the
cellular distribution of Rho3 to affect its function. These factors include Cdc42 and
exocyst localization143,

144

and, as shown here, Erf2-mediated palmitoylation. I am

currently constructing strains that express palmitoylation-deficient Rho3 to confirm this.
The role of Rho3 palmitoylation may then be tested by looking at trafficking of known
cycling substrates (e.g. vesicular SNAREs), secretion of acid phosphatase as well as
endocytosis and vacuole sizes (FM4-64, membrane markers) in cells expressing wild type
and palmitoylation-deficient Rho3. Delivery of cytoplasmic vesicles to discrete plasmamembrane domains is critical for establishing and maintaining cell polarity, neurite
differentiation and regulated exocytosis. Anastasia and co-workers showed that blocking
membrane traffic causes a mitotic checkpoint, suggesting a link between mitotic entry
and membrane growth in budding yeast175. If Rho3 palmitoylation affects membrane
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trafficking, signals that are coupled to membrane growth may explain how Rho3
regulates meiotic entry in fission yeast. These signals may be increased concentration of
receptors and effectors at the plasma membrane or simply non-specific stress signaling as
a result of defective membrane trafficking or cytoskeleton organization. The identity of
these signals are unknown (Fig. 5.2b).

Figure 5.2 | Model for coordination of membrane trafficking and polarized exocytosis by
Rho3 in S. pombe. a, Rho3 may coordinate parallel actin-dependent and exocyst-dependent
secretory pathways. Cdc42 sets up cell polarity and regulates two parallel morphogenetic
modules for polarized cell growth, the formin-dependent actin cable module and the exocyst
module, contributing to transport and tethering of exocytic vesicles, respectively. The exocyst is
also controlled by PIP2 levels at the plasma membrane. Actin patches, and thus endocytosis, may
contribute to maintaining polarized localization of Cdc42 and the exocyst. An effector of Rho3,
For3 binds to both active forms of Cdc42 and Rho3. Rho3 localization is dependent on the
exocyst but not vice versa. b, Speculative model of compartmentalized Rho3 signaling. # depicts
the different factors such as cytoskeleton, exocyst function and palmitoylation may affect Rho3
distribution, which in turn affect its function by signaling though different effectors. How these
different signals are integrated and contribute to meiotic entry are not known. PM: plasma
membrane.
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Multiple Erf2-Erf4 functions
Although I chose to focus on meiosis for my thesis, Erf2-Erf4 function is implicated in
multiple cellular processes including stress response, mating, meiosis and sporulation.
This raises an important question - how does a single PAT selectively control and
coordinate these different pathways? This may be achieved via different substrates and
we showed here that substrates of the same PAT can be differentially modified simply by
changing PAT activity levels. It will be worthwhile to catalog the different Erf2 substrates
that are modified during each of the cellular events and determine if their palmitoylation
states affect coordination of these temporally separated processes: stress response ➔
mating ➔ meiosis ➔ sporulation.
As shown by others and in our study, palmitoylation is not an all-or-nothing
process and the steady state palmitoylation levels of a specific substrate can vary over a
large range. While I have focused on the high and low palmitoylation levels of Rho3 in
meiotic and vegetative cells respectively, it remains to be seen if intermediate Rho3
palmitoylation has a function in the different cellular processes. In the case of PSD95,
whose palmitoylation has been shown to affect synaptic clustering and signaling
strength39, 51, 176‐178, one expects a positive correlation between synaptic strength and the
levels of steady state PSD95 palmitoylation.

Model organisms and technical advances are important for new discoveries
Technical difficulties in palmitoyl enzymology and detection/analysis hindered
palmitoylation studies for more than 30 years since the initial discovery of the
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modification179. In the last decade, the use of model organisms and technical advances in
the detection and analysis of palmitoylation have propelled this emerging field (Fig. 5.1).
Yeast genetics have proven fruitful in landmark discovery of the PATs as the main
palmitoylating enzymes57,

58, 63

when biochemical attempts to purify them were

complicated by the instability of these enzymes once they are extracted from
membranes180, 181. The budding yeast model has been and continues to be instrumental in
our understanding of PAT specificity12, 66, 69 and mechanism of palmitate transfer61, 62.
The advent of the acyl-biotin exchange protocol as well as bioorthogonal
chemical reporters described in this thesis enabled identification of palmitoylomes,
greatly expanding the scope of the modification and providing unprecedented insights
into the cellular function of palmitoylation. Furthermore, these two approaches allowed
robust non-radioactive detection of palmitoylated proteins expressed at endogenous
levels, reducing experimental times and enabling faster testing of hypotheses.
Advanced microscopy techniques, in combination with semi-synthetic
lipopeptides, offer unprecedented insights into the dynamics of protein palmitoylation.
Photo-activation/bleaching of fluorescent palmitoylated proteins estimate protein-bound
palmitate to turnover in milliseconds or seconds22, 24, which is consistent with rapid
physiological responses that can occur on the seconds time scale. This is in contrast to
biochemical pulse-chase experiments, which yield palmitate half-life measurements in
the order of minutes or hours potentially due to rapid recycling of the labeled fatty acid
analogs. Use of semi-synthetic proteins irreversibly linked to palmitate definitively
showed the importance of the reversibility of the modification and how palmitate cycling
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contributes to cellular distribution of modified proteins22. More recently, the design of a
specific APT inhibitor, Palmostatin B83, 84, potentially allows rapid temporal control of
depalmitoylation activity and further dissection of the palmitoylation kinetics in cells.
Together, these technical advances are beginning to reveal mechanistic and
functional insights into the effect dynamic palmitoylation exerts on physiology and
disease but tool development will continue to be critical for progress in the field. For
example, there is still a need for specific PAT inhibitors since most existing
palmitoylation inhibitors such as 2-bromopalmitate have pleiotropic effects on lipid
metabolism128. On a similar note, development of activity-based probes that selectively
react with active PATs or thioesterases will not only allow one to profile the functional
states of these enzymes in normal and disease models (Fig. 5.3a), but also aid in the
development of specific inhibitors. In addition, solving the structures of PATs will
invaluable towards understanding the mechanism of palmitate transfer to substrates and
origin of substrate selectivity as well as greatly facilitate the design of selective activitybased probes and inhibitors. Understanding what dictates enzyme:substrate specificity
will further help development of approaches that allows control of the palmitoylation
state of specific proteins of interest. For instance, one can imagine engineering specificity
determinants that can be appended onto a PAT and a protein of interest such that the
latter will only be modified when this orthogonal PAT is expressed. Last but not least,
given the evidence for interactions between different PTMs, palmitoylation should not be
studied in isolation but in conjunction with other modifications, especially
phosphorylation and other cysteine modifications.
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Figure 5.3 | Activity-based probes for palmitoylation studies. Activity-based probes (selective
chemically reactive group with a detection/affinity handle) that specifically react with active PATs
or thioesterases enable the profiling of functional states of the enzymes in normal and disease
models. Figure adapted from the Cravatt lab (Scripps) website.

Concluding remarks
In conclusion, we have developed chemical strategies to efficiently detect and identify
palmitoylated proteins in mammalian systems and by applying them in an alternative S.
pombe model, uncovered a mechanism by which PATs regulate global protein
palmitoylation as well as important cellular events such as meiosis. Our study also
highlights the importance of studying the regulation and function of protein
palmitoylation in physiologically relevant contexts. This is perhaps best demonstrated by
a series of studies in neurons, which collectively showed that neuronal activity-driven
regulation of PAT localization and protein nitrosylation modulates protein palmitoylation,
which in turn modulates neuronal morphogenesis, receptor clustering and synaptic
strength39, 40, 51, 65, 177, 178. In this thesis, we introduced a genetically tractable system with
relatively simple enzymatic machinery and substrate “catalog” that is valuable towards
understanding basic principles and control mechanisms of protein palmitoylation in a
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physiological context. This work exemplifies how chemical strategies may be used in the
fission yeast system to study the PAT-mediated regulation of palmitoylation and the
associated effects on cellular physiology. In the process, new questions about multiple
PAT functions, differential substrate specificity and potential regulatory roles of
palmitoylation are generated, which can be systematically tested using this system. The
next few years represent a challenging and exciting time that promises to reveal
fundamental insights into protein palmitoylation, which one hopes may one day lead to
novel therapeutic strategies to control diverse physiological processes.
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APPENDIX 1 - Proteomics data (Pages 134-146)
Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

DMSO

alk-16

DMSO

alk-16

Net
counts

DMSO

alk-16

Isp3

SPAC1F8.05

20

3

2

30

99

69

8

4

P-type ATPase

SPAC6C3.06c

117

0

7

0

14

14

9

9

Vps13b

SPBC16C6.02c

339

4

3

0

11

11

4

4

Rho3

SPAC23C4.08

23

0

2

0

11

11

0

0

Sir2

SPBC16D10.07c

53

4

7

0

8

8

0

0

Noc1

SPAC4F10.09c

98

2

4

0

8

8

0

3

Rad24

SPAC8E11.02c

30

7

10

0

6

6

0

3

Cid11

SPBC1685.06

55

4

6

0

6

6

0

0

Dcr1

SPCC188.13c

158

3

0

0

6

6

0

3

Pre5

SPAC6G10.04c

30

0

0

0

6

6

0

0

Gpd1

SPBC215.05

42

0

2

0

6

6

2

3

Hxk1

SPAC24H6.04

54

0

2

0

6

6

0

2

Sak1

SPAC3G9.14

86

3

0

0

5

5

0

2

Ferric-chelate
reductase

SPBC947.05c

65

2

2

0

5

5

2

2

Ucp8

SPBC83.01

98

0

0

0

5

5

0

0

Mss1

SPAC222.05c

55

0

0

0

5

5

0

0

Pli1

SPAC1687.05

81

0

0

0

5

5

0

0

Non classical export
pathway protein

SPBC1685.13

20

0

0

0

5

5

0

0

Top1

SPBC1703.14c

94

0

0

0

5

5

0

2
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Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Alpha,alphatrehalose-phosphate
synthase

SPACUNK4.16c

107

0

0

0

5

5

0

2

UPF0061 family
protein

SPAC20G4.05c

64

0

0

0

5

5

0

2

Nep1

SPBC17D11.01

47

0

2

0

5

5

0

0

Adf1

SPAC20G4.06c

16

0

2

0

5

5

0

0

Trk1

SPAC3F10.02c

96

0

4

4

9

5

2

0

Rpl14

SPAC1805.13

15

9

16

0

4

4

0

0

Uso1

SPAC29E6.03c

122

4

6

0

4

4

0

0

Oxa101

SPAC9G1.04

42

3

0

0

4

4

0

2

Spt8

SPBC14C8.17c

58

3

2

0

4

4

0

0

Hrp3

SPAC3G6.01

159

3

4

0

4

4

4

6

Cytoskeletal protein
binding protein Sla1
family

SPAC16E8.01

155

2

0

0

4

4

0

0

Membrane
transporter

SPAC3H1.06c

64

2

0

0

4

4

0

0

Ptc4

SPAC4A8.03c

44

2

2

0

4

4

0

0

Rhp54

SPAC15A10.03c

97

2

2

0

4

4

0

2

Rpl22

SPAC11E3.15

13

2

2

0

4

4

0

2

NAD/NADH kinase

SPAC3H5.11

45

2

3

0

4

4

2

3

Sir1

SPAC10F6.01c

164

2

3

0

4

4

0

0

Vps4

SPAC2G11.06

48

0

0

0

4

4

2

0

Klp8

SPAC144.14

57

0

0

0

4

4

2

0

Coq3

SPCC162.05

30

0

0

0

4

4

2

0

Lhs1

SPAC1F5.06

95

0

0

0

4

4

2

2
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Rsc7

SPCC1281.05

44

0

0

0

4

4

0

0

cdc23

SPBC1347.10

67

0

0

0

4

4

0

0

DuF1740 family
protein

SPBC20F10.05

113

0

0

0

4

4

0

0

Conserved fungal
protein

SPCPB16A4.02c

38

0

0

0

4

4

0

0

Grx3

SPCC1450.06c

18

0

0

0

4

4

0

0

Suc22

SPBC25D12.04

45

0

0

0

4

4

0

0

Ght5

SPCC1235.14

60

0

0

0

4

4

0

0

FAD-dependent
amino acid oxidase

SPAC6G10.06

42

0

0

0

4

4

0

0

Rrp6

SPAC1F3.01

90

0

0

0

4

4

0

0

Htb1

SPCC622.09

14

0

0

0

4

4

0

0

zf-CCHC type zinc
finger protein

SPAC683.02c

25

0

0

0

4

4

0

0

Ptc2

SPCC1223.11

41

0

0

0

4

4

0

0

ATP-dependent RNA
helicase, eIF4A
related

SPAC1F5.10

45

0

0

0

4

4

0

0

Rds1

SPAC343.12

44

0

0

0

4

4

0

0

Shf1

SPAC22F8.12c

19

0

0

0

4

4

0

2

Aif1

SPAC26F1.14c

62

0

0

0

4

4

0

2

Ppp1

SPBC19F5.05c

69

0

0

0

4

4

0

2

Mrpl32

SPBC1604.13c

12

0

0

0

4

4

0

2

Rpn2

SPBC17D11.07c

107

0

2

0

4

4

4

2

Ubp22

SPCC188.08c

129

0

2

0

4

4

4

3

Pga2

SPBC27.01c

16

0

2

0

4

4

3

2
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Arh1

SPBC3B8.01c

53

0

2

0

4

4

3

3

Spt5

SPAC23C4.19

109

0

2

0

4

4

2

0

Conserved eukaryotic
protein

SPAC1687.04

57

0

2

0

4

4

0

0

Sequence orphan

SPBC405.02c

50

0

2

0

4

4

0

0

Str2

SPCC61.01c

66

0

2

0

4

4

0

2

transcription factor,
zf-fungal binuclear
cluster type

SPAC1399.05c

61

3

3

0

3

3

0

0

RNA binding protein

SPAC4G8.03c

88

2

2

0

3

3

0

0

Dbp9

SPCC1494.06c

67

2

2

0

3

3

0

0

guanyl-nucleotide
exchange factor

SPAC11E3.11c

106

0

0

0

3

3

3

3

Mcm3

SPCC1682.02c

97

0

0

0

3

3

3

4

Pig-F

SPCC1450.15

57

0

0

0

3

3

2

2

Ubiquitin-protein
ligase E3

SPBC947.10

77

0

0

0

3

3

2

2

Yop1

SPCC830.08c

21

0

0

0

3

3

2

2

Sequence orphan

SPAC821.03c

54

0

0

0

3

3

2

3

Sequence orphan

SPAC13G7.09c

16

0

0

0

3

3

0

0

AAA family ATPase,
unknown biological
role

SPBC947.01

72

0

0

0

3

3

0

0

Sec6

SPCC1235.10c

83

0

0

0

3

3

0

0

Ulp1

SPBC19G7.09

65

0

0

0

3

3

0

0

Apl4

SPCP1E11.06

96

0

0

0

3

3

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

D123 family

SPAP27G11.03

37

0

0

0

3

3

0

0

Hst4

SPAC1783.04c

47

0

0

0

3

3

0

0

Pinin homolog

SPAC26F1.02

23

0

0

0

3

3

0

0

CorA family
magnesium ion
transporter

SPAC17A2.14

71

0

0

0

3

3

0

0

Aspartate kinase

SPBC19F5.04

57

0

0

0

3

3

0

0

Fumarate lyase
superfamily

SPBC8E4.05c

50

0

0

0

3

3

0

0

Transcription factor

SPAPB1A11.04c

79

0

0

0

3

3

0

0

tRNA
nucleotidyltransferas
e

SPAC1093.04c

58

0

0

0

3

3

0

0

WD repeat protein,
human WDR55
family

SPAC1A6.02

40

0

0

0

3

3

0

0

Biotin-protein ligase

SPBC30D10.07c

71

0

0

0

3

3

0

0

Transcription factor

SPBC19C7.10

48

0

0

0

3

3

0

0

Ctf1

SPBC3B9.11c

40

0

0

0

3

3

0

0

Sec15

SPCC1183.01

91

0

0

0

3

3

0

0

Nak1

SPBC17F3.02

71

0

0

0

3

3

0

0

Rpt6

SPBC23G7.12c

45

0

0

0

3

3

0

0

Nucleoporin
Nup157/170

SPAC890.06

148

0

0

0

3

3

0

0

Mitochondrial citrate
transporter

SPAC19G12.05

32

0

0

0

3

3

0

0

Amidase

SPAC869.01

65

0

0

0

3

3

0

0

Uve1

SPBC19C7.09c

69

0

0

0

3

3

0

0

Leu3

SPBC3E7.16c

64

0

0

0

3

3

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Adaptin

SPAC1F3.05

57

0

0

0

3

3

0

0

Ubp6

SPAC6G9.08

52

0

0

0

3

3

0

0

ZIP zinc transporter 1

SPAP8A3.03

50

0

0

0

3

3

0

0

Taf1

SPAC1002.04c

23

0

0

0

3

3

0

0

Phx1

SPAC32A11.03c

104

0

0

0

3

3

0

0

Pex7

SPAC17D4.01

35

0

0

0

3

3

0

0

Gln1

SPAC23H4.06

40

0

0

0

3

3

0

0

Ptr6

SPAC13F5.02c

45

0

0

0

3

3

0

0

Ubi1

SPAC11G7.04

15

0

0

0

3

3

0

0

Las1-like protein

SPBC16C6.12c

54

0

0

0

3

3

0

0

Gpi18

SPAC18B11.05

49

0

0

0

3

3

0

0

AMP-activated
protein kinase beta
subunit

SPCC1919.03c

33

0

0

0

3

3

0

0

Cbs2

SPAC1556.08c

37

0

0

0

3

3

0

0

Sdh3

SPCC330.12c

20

0

0

0

3

3

0

0

DUF726 family
protein

SPAC607.08c

64

0

0

3

6

3

0

3

Sti1

SPCC645.14c

66

0

2

2

5

3

3

3

Pmc2

SPAC2F7.04

51

3

4

0

2

2

0

0

Rps21

SPBC18E5.06

10

3

5

0

2

2

0

0

Lsk1

SPAC2F3.15

67

2

2

0

2

2

0

0

Swi2

SPAC1142.03c

82

2

2

0

2

2

0

0

Dbp3

SPBC17D1.06

64

2

2

0

2

2

0

0

PQ loop protein

SPAC2E12.03c

32

2

3

0

2

2

3

5
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Ypt3

SPAC18G6.03

24

2

3

0

2

2

0

0

TRP-like ion channel

SPCC663.14c

77

0

0

0

2

2

2

2

Irs1

SPBC8D2.06

123

0

0

0

2

2

2

3

Lsd90

SPBC16E9.16c

82

0

0

0

2

2

2

3

Pdt1

SPAC27F1.08

58

0

0

0

2

2

2

3

alpha-1,2mannosyltransferase

SPBC16H5.09c

44

0

0

0

2

2

2

3

Rec11

SPCC4E9.01c

107

0

0

0

2

2

0

0

Conserved fungal
protein

SPCC1494.08c

31

0

0

0

2

2

0

0

Nat10

SPAC20G8.09c

116

0

0

0

2

2

0

0

Abp2

SPBC1861.02

60

0

0

0

2

2

0

0

Sid4

SPBC244.01c

74

0

0

0

2

2

0

0

Aminotransferase
class-III, unknown
specificty

SPAC27F1.05c

53

0

0

0

2

2

0

0

Mfh1

SPAC9.05

97

0

0

0

2

2

0

0

Conserved fungal
protein

SPAC2F3.14c

38

0

0

0

2

2

0

0

Glc9

SPAC17A5.09c

35

0

0

0

2

2

0

0

Sequence orphan

SPBC2G2.14

60

0

0

0

2

2

0

0

Atp23

SPCC320.12

22

0

0

0

2

2

0

0

Spermidine family
transporter

SPBC36.03c

59

0

0

0

2

2

0

0

Mug100

SPBC16E9.07

36

0

0

0

2

2

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

DUF1716 family
protein

SPAC1952.06c

65

0

0

0

2

2

0

0

Ltv1

SPAC3F10.17

44

0

0

0

2

2

0

0

Arg7

SPBC1773.14

52

0

0

0

2

2

0

0

Cmk1

SPACUNK12.02c

38

0

0

0

2

2

0

0

Mitochondrial tRNA

SPAC12B10.08c

52

0

0

0

2

2

0

0

Ran GTP-binding
protein

SPAC31A2.10

51

0

0

0

2

2

0

0

Acetyl-CoA
hydrolase

SPAC1952.09c

58

0

0

0

2

2

0

0

C2 domain protein

SPCC962.01

156

0

0

0

2

2

0

0

Transcription factor

SPAC105.03c

81

0

0

0

2

2

0

0

Arrestin/ PY protein
1

SPAC31A2.12

66

0

0

0

2

2

0

0

Tht1

SPAC13C5.03

63

0

0

0

2

2

0

0

Sbh1

SPBC2G2.03c

10

0

0

0

2

2

0

0

Nap1

SPCC364.06

44

0

0

0

2

2

0

0

Sequence orphan

SPAC7D4.13c

36

0

0

0

2

2

0

0

Ark1

SPCC320.13c

41

0

0

0

2

2

0

0

Svf1

SPCC584.11c

43

0

0

0

2

2

0

0

LEA domain protein

SPAC23C4.05c

50

0

0

0

2

2

0

0

Short chain
dehydrogenase

SPAC19A8.06

45

0

0

0

2

2

0

0

TLDc domain protein
2

SPBC21.02

59

0

0

0

2

2

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

NADPH-dependent
diflavin
oxidoreductase

SPAC1296.06

64

0

0

0

2

2

0

0

Gma12

SPCC736.04c

43

0

0

0

2

2

0

0

Rsv2

SPBC1105.14

69

0

0

0

2

2

0

0

Pgp1

SPCC1259.10

46

0

0

0

2

2

0

0

Mep33

SPBC28F2.02

33

0

0

0

2

2

0

0

Rft1

SPBC887.19

60

0

0

0

2

2

0

0

Mitochondrial mAAA protease

SPBC543.09

85

0

0

0

2

2

0

0

Hta2

SPAC19G12.06c

14

0

0

0

2

2

0

0

Rae1

SPBC16A3.05c

39

0

0

0

2

2

0

0

Hhp1

SPBC3H7.15

42

0

0

0

2

2

0

0

Wee1

SPCC18B5.03

96

0

0

0

2

2

0

0

Pfs2

SPAC12G12.14c

58

0

0

0

2

2

0

0

Cytoskeletal
signaling protein

SPAC637.13c

56

0

0

0

2

2

0

0

Mcp2

SPCC1682.08c

79

0

0

0

2

2

0

0

Mug73

SPCC31H12.02c

35

0

0

0

2

2

0

0

Mbx1

SPBC19G7.06

51

0

0

0

2

2

0

0

Apc11

SPAC343.03

11

0

0

0

2

2

0

0

Nudix family
hydrolase

SPAC14C4.10c

38

0

0

0

2

2

0

0

DUF544 family
protein

SPAC12G12.11c

42

0

0

0

2

2

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Ppk29

SPBC557.04

96

0

0

0

2

2

0

0

Rfc2

SPAC23D3.02

38

0

0

0

2

2

0

0

Sgf29

SPBC1921.07c

28

0

0

0

2

2

0

0

Nicotinic acid plasma
membrane transporter

SPAC1002.16c

55

0

0

0

2

2

0

0

Peptidase

SPCC1259.02c

92

0

0

0

2

2

0

0

Steriod
dehydrogenase

SPAC7D4.09c

32

0

0

0

2

2

0

0

Rhp18

SPBC1734.06

43

0

0

0

2

2

0

0

Membrane
transporter

SPCC965.13

60

0

0

0

2

2

0

0

RINT1 family protein

SPBC691.02c

79

0

0

0

2

2

0

0

Rad17

SPAC14C4.13

69

0

0

0

2

2

0

0

Ura3

SPAC57A10.12c

48

0

0

0

2

2

0

0

Fun1

SPCC18.18c

56

0

0

0

2

2

0

0

Erv41

SPBC2G5.04c

38

0

0

0

2

2

0

0

Sce3

SPBC18H10.04c

43

0

0

0

2

2

0

0

IMP 5'-nucleotidase

SPBC30D10.03c

46

0

0

0

2

2

0

0

Rax2

SPAC6F6.06c

128

0

0

0

2

2

0

0

CTNS domain
protein

SPAC4C5.03

34

0

0

0

2

2

0

0

Nup120

SPBC3B9.16c

130

0

0

0

2

2

0

0

Asa1

SPAC1006.02

41

0

0

0

2

2

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Sequence orphan

SPAC24C9.04

14

0

0

0

2

2

0

0

Spp2

SPBC17D11.06

53

0

0

0

2

2

0

0

Clr2

SPAC1B3.17

62

0

0

0

2

2

0

0

Tea1

SPCC1223.06

127

0

0

0

2

2

0

0

Sequence orphan

SPAC17A2.07c

20

0

0

0

2

2

0

0

Nab2

SPAC14C4.06c

34

0

0

0

2

2

0

0

Conserved protein

SPAC6G9.01c

10

0

0

0

2

2

0

0

Ubiquitin-protein
ligase E3

SPBC16G5.03

31

0

0

0

2

2

0

0

Atp6

SPMIT.07

28

0

0

0

2

2

0

0

Histone
acetyltransferase
complex subunit

SPAC25H1.06

47

0

0

0

2

2

0

0

SRR1 family protein

SPBC14C8.13

29

0

0

0

2

2

0

0

Sgf11

SPAC57A10.14

13

0

0

0

2

2

0

0

Atf31

SPAC22F3.02

24

0

0

0

2

2

0

0

Swd1

SPAC23H3.05c

45

0

0

0

2

2

0

0

Short chain
dehydrogenase

SPAC977.08

26

0

0

0

2

2

0

0

Eng2

SPAC23D3.10c

78

0

0

0

2

2

0

0

Swd1

SPBC354.02c

53

0

0

0

2

2

0

0

Mis16

SPCC1672.10

48

0

0

0

2

2

0

0

144

Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Membrane
transporter

SPCC417.10

57

0

0

0

2

2

0

0

Psy1

SPCC825.03c

33

0

0

0

2

2

0

0

Moc3

SPAC821.07c

55

0

0

0

2

2

0

0

RNA-binding
protein, G-patch type

SPAC2G11.04

33

0

0

0

2

2

0

0

Cwf20

SPCC4B3.14

33

0

0

0

2

2

0

0

Mug117

SPCC645.11c

22

0

0

0

2

2

0

0

DUF1000 family
protein

SPBP35G2.02

23

0

0

0

2

2

0

0

Mitochondrial
ribosomal protein
subunit L9

SPCC777.17c

12

0

0

0

2

2

0

0

ORMDL family
protein

SPBC119.09c

21

0

0

0

2

2

0

0

Tif212

SPAC32A11.04c

36

0

0

0

2

2

0

0

Mdm10

SPAC17H9.17c

42

0

0

0

2

2

0

0

tRNA specific
adenosine deaminase

SPBC16A3.06

44

0

0

0

2

2

0

0

Hem2

SPAC1805.06c

36

0

0

0

2

2

0

0

Imidazoleglycerolphosphate synthase

SPAC222.08c

26

0

0

0

2

2

0

0

Diacylglycerol
cholinephosphotranfe
rase/ diacylglycerol
ethanolaminesphotra
nferase

SPAC22A12.10

44

0

0

0

2

2

0

0

Metal dependent
phosphohydrolase

SPCC4G3.17

23

0

0

0

2

2

0

0
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Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)

Identified proteins

Accession
Number

MW
(kDa)

Vegetative WT
(spectral counts)

Gpi12

SPAPB2B4.01c

28

0

0

0

2

2

0

0

tspO homolog

SPBC725.10

18

0

0

0

2

2

0

0

Btn1

SPAC607.09c

44

0

0

0

2

2

0

0

Sequence orphan

SPBPB21E7.05

15

0

0

0

2

2

0

0

Amino acid
permease, unknown
15

SPCC74.04

60

0

0

0

2

2

0

0

Rng3

SPCC613.04c

84

0

0

2

4

2

0

0

146

Meiotic WT
(spectral counts)

Meiotic erf2Δ
(spectral counts)
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